Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Biotechnol Adv. 2013 Nov 16;32(4):711–726. doi: 10.1016/j.biotechadv.2013.11.006

Techniques for physicochemical characterization of nanomaterials

Ping-Chang Lin a, Stephen Lin a, Paul C Wang a, Rajagopalan Sridhar b,*
PMCID: PMC4024087  NIHMSID: NIHMS564826  PMID: 24252561

Abstract

Advances in nanotechnology have opened up a new era of diagnosis, prevention and treatment of diseases and traumatic injuries. Nanomaterials, including those with potential for clinical applications, possess novel physicochemical properties that have an impact on their physiological interactions, from the molecular level to the systemic level. There is a lack of standardized methodologies or regulatory protocols for detection or characterization of nanomaterials. This review summarizes the techniques that are commonly used to study the size, shape, surface properties, composition, purity and stability of nanomaterials, along with their advantages and disadvantages. At present there are no FDA guidelines that have been developed specifically for nanomaterial based formulations for diagnostic or therapeutic use. There is an urgent need for standardized protocols and procedures for the characterization of nanoparticles, especially those that are intended for use as theranostics.

Keywords: Nanoparticle, Nanomedicine, Physicochemical properties, Image contrast agents, Molecular imaging

1. Introduction

The emerging field of nanomedicine utilizes nanomaterials to improve diagnosis, prevention and treatment of diseases (Duncan and Gaspar, 2011). According to the Nanotechnology Characterization Laboratory (NCL) at the National Cancer Institute, National Institutes of Health nanoparticles (NPs) have a size range between 1 and 100 nm (McNeil, 2005). Nanomaterials have at least one dimension in the range of sub-nanometer to 10 nm. Small molecules and certain naturally occurring biological materials are not usually referred to as nanomaterials, even though they may be in the range of 1 to 100 nm. Research on manmade nanomaterials and engineered nanomaterials in the 1 to 100 nm range has gathered momentum because of their potential for a diverse array of applications in science, technology and medicine (Webster, 2006). Some examples of nanomaterials include liposomes, dendrimers, carbon nanorods, carbon nanotubes, fullerenes, graphene derivatives, titanium oxides, gadolinium nitride nanowires, silver NPs, gold NPs, platinum NPs, magnetic NPs and quantum dots (Duncan and Gaspar, 2011; Mahajan et al., in press; Singh and Sahoo, in press; Wong et al., in press).

When a solid is split, it exposes two new surfaces; with every subsequent cut, newer surfaces emerge. As any material is broken down to very small particles, the surface area per unit mass increases dramatically. Nanomaterials are characterized by a relatively large surface area per unit mass. Since the surface area of a solid depends on its shape, e.g. a sphere has the smallest surface area per unit mass, the surface area of nanomaterials depends on the size as well as shape. Changes in size or shape of nanomaterials can affect their physicochemical and physiological properties.

The physiological interactions in the body influenced by the biodistribution, passage, phagocytosis and endocytosis of nanomaterials through tissues may differ from those of conventional medicines (Gref et al., 1994). In order to realize the full potential of nanomedicines, it is necessary to develop robust standards for characterizing the engineered/fabricated nanomaterials, for example, to provide a guidance for ensuring quality control and assessing the safety as well as toxicity of nanomaterials (Pleus, 2012). Characteristics such as molecular structure, chemical composition, melting point, boiling point, vapor pressure, flash point, pH, solubility, and water octanol partition coefficient have to be determined for nanomaterials in the same manner as they are for larger non-nanomaterials. In addition, nanomaterial characterization places special emphasis on parameters such as size/size distribution, porosity (pore size), surface area, shape, wettability, zeta potential, adsorption isotherm (adsorption potential), aggregation, distribution of conjugated moieties and impurities.

At present there are no U.S. Food and Drug Administration (FDA) guidelines developed specifically for nanomaterial based formulations for diagnostic or therapeutic use. However, the agency has issued two product-specific draft guidance documents to address the utilization of nanotechnology in the food and cosmetics industries (http://www.fda.gov/ScienceResearch/SpecialTopics/Nanotechnology/ucm301093.htm). This can be a stepping stone towards detection or characterization of nanomaterials, although currently there are no standardized methodologies or regulatory protocols. Still, the NCL, serving as “a national resource and knowledge base” to assist the regulatory review of nanotechnologies and the development and translation of nanoparticles and devices for clinical applications, characterizes the physicochemical properties, in vitro biological properties and in vivo compatibility of nanoparticles (http://ncl.cancer.gov/about_mission.asp). The assay cascade protocols at the NCL include a number of methods to investigate nanomaterials' characteristics, such as size, molecular weight, aggregation, purity, chemical composition and surface properties. The NCL protocols also include methods for determining sterility, drug release and toxicity in vitro, and efficacy, disposition and immunotoxicity in vivo (http://ncl.cancer.gov/working_assay-cascade.asp). Similarly, the European Union has formed the unit of Registration, Evaluation, Authorization and Restriction of Chemicals, by which nanomaterials are regulated.

Many methods have been used for evaluating manufactured nanomaterials, including techniques in optical spectroscopy, electron microscopy, surface scanning, light scattering, circular dichroism, magnetic resonance, mass spectrometry, X-ray scattering and spectroscopy, and zeta-potential measurements, as well as methods in the categories of thermal techniques, centrifugation, chromatography, and electrophoresis (Sapsford et al., 2011). In this review article, we briefly describe the principles, applications, strengths and limitations of a variety of modalities commonly used to investigate the physicochemical characteristics of nanomaterials (Table 1).

Table 1.

Analytical modalities for evaluation of the physicochemical characteristics of nanomaterials.

Techniques Physicochemical
characteristics analyzed
Strengths Limitations Refs
Dynamic light scattering (DLS) Hydrodynamic size distribution Non-destructive/invasive manner
Rapid and more reproducible measurement
Measures in any liquid media, solvent of interest
Hydrodynamic sizes accurately determined for monodisperse samples
Modest cost of apparatus
Insensitive correlation of size fractions with a specific composition
Influence of small numbers of large particles
Limit in polydisperse sample measures
Limited size resolution
Assumption of spherical shape samples
Brar and Verma (2011); Domingos et al. (2009); Filipe et al. (2010); Murdock et al. (2008); Pan et al. (2013); Sapsford et al. (2011); Schacher et al. (2009); Wagner et al. (2007); Zhao et al. (2013)
Fluorescence correlation spectroscopy (FCS) Hydrodynamic dimension
Binding kinetics
High spatial and temporal resolution
Low sample consumption
Specificity for fluorescent probes
Method for studying chemical kinetics, molecular diffusion, concentration effect, and conformation dynamics
Limit in fluorophore species
Limited applications and inaccuracy due to lack of appropriate models
Boukari and Sackett (2008); Domingos et al. (2009); Jing and Zhu (2011); Nienhaus et al. (2013); Sapsford et al. (2011)
Zeta potential Stability
Referring to surface charge
Simultaneous measurement of many particles (using ELS) Electro-osmotic effect
Lack of precise and repeatable measurement
Choi et al. (2011); Clogston and Patri (2011); Khatun et al. (2012); Sapsford et al. (2011); Weiner et al. (1993); Xu (2008)
Raman scattering (RS)
  Surface enhanced Raman (SERS)
  Tip-enhanced Raman spectroscopy (TERS)
Hydrodynamic size and size distribution (indirect analysis)
Conformation change of protein–metallic NP conjugate
Structural, chemical and electronic properties
Complementary data to IR
No requirement of sample preparation
Potential of detecting tissue abnormality
Enhanced RS signal (SERS)
Increased spatial resolution (SERS)
Topological information of nanomaterials (SERS, TERS)
Relatively weak single compared to Rayleigh scattering
Limited spatial resolution (only to micrometers)
Extremely small cross section
Interference of fluorescence
Irreproducible measurement (SERS)
Kumar (2012); Popovic et al. (2011); Chang et al. (2012); Kattumenu et al. (2012); Kneipp et al. (2010); Kumar and Thomas (2011); Mannelli and Marco (2010); Braun et al. (2009); Lin and Chang (2007); Lucas and Riedo (2012); Sinjab et al. (2012); Xiao et al. (2010)
Near-field scanning optical microscopy (NSOM) Size and shape of nanomaterials Simultaneous fluorescence and spectroscopy measurement
Nano-scaled surface analysis at ambient conditions
Assessment of chemical information and interactions at nano-scaled resolution
Long scanning time
Small specimen area analyzed
Incident light intensity insufficient to excite weak fluorescent molecules
Difficulty in imaging soft materials
Analysis limited to the nanomaterial surface
Cuche et al. (2009); Kohli and Mittal (2011); Lin et al. (2012); Lucas and Riedo (2012); Pan et al. (2013); Park et al. (2008); Vancso et al. (2005)
Circular dichroism (CD) Structure and conformational change of biomolecules (e.g. protein and DNA)
Thermal stability
Nondestructive and prompt technique Non-specificity of residues involved in conformational change
Less sensitive than absorption methods
Weak CD signal for non-chiral chromophores
Challenging for analysis of molecules containing multiple chiral chromophores
Caminade et al. (2005); Ghosh et al. (2007); Huang et al. (2013b); Jiang et al. (2004); Knoppe et al. (2010); Kobayashi et al. (2011); Liu and Webster (2007); Ranjbar and Gill (2009); Ratnikova et al. (2011); Sapsford et al. (2011); Shang et al. (2007)
Mass spectroscopy (MS) Molecular weight
Composition Structure
Surface properties (secondary ion MS)
High accuracy and precision in measurement
High sensitivity to detection (a very small amount of sample required)
Expensive equipment
Lack of complete databases for identification of molecular species
Limited application to date in studying nanomaterial-bioconjugates
Gmoshinski et al. (2013); Knoppe et al. (2010); Lavigne et al. (2013); Sapsford et al. (2011); Tang et al. (2010); Tiede et al. (2008)
Infrared spectroscopy (IR)
  Attenuated total reflection
  Fourier transform infrared (ATR–FTIR)
Structure and conformation of bioconjugate
Surface properties (ATR–FTIR)
Fast and inexpensive measurement
Minimal or no sample preparation requirement (ATR–FTIR)
Improving reproducibility (ATR–FTIR)
Independence of sample thickness (ATR–FTIR)
Complicated sample preparation (IR)
Interference and strong absorbance of H2O (IR)
Relatively low sensitivity in nanoscale analysis
Gun'ko et al. (2009); Johal (2011); Kane et al. (2009); Kazarian and Chan (2006); Liu and Webster (2007); Zak et al. (2011); Zhao et al. (2008)
Scanning electron microscopy (SEM)
  Environmental SEM (ESEM)
Size and size distribution
Shape
Aggregation
Dispersion
Direct measurement of the size/size distribution and shape of nanomaterials
High resolution (down to sub-nanometer)
Images of biomolecules in natural state provided using ESEM
Conducting sample or coating conductive materials required
Dry samples required
Sample analysis in non-physiological conditions (except ESEM)
Biased statistics of size distribution in heterogeneous samples
Expensive equipment
Cryogenic method required for most NP-bioconjugates
Reduced resolution in ESEM
Bernier et al. (2012); Boguslavsky et al. (2011); Bootz et al. (2004); Hall et al. (2007); Jin et al. (2010); Johal (2011); Ratner et al. (2004); Sapsford et al. (2011); Tiede et al. (2008)
Transmission electron microscopy (TEM) Size and size distribution
Shape heterogeneity
Aggregation
Dispersion
Direct measurement of the size/size distribution and shape of nanomaterials with higher spatial resolution than SEM
Several analytical methods coupled with TEM for investigation of electronic structure and chemical composition of nanomaterials
Ultrathin samples in required
Samples in nonphysiological condition
Sample damage/alternation
Poor sampling
Expensive equipment
Cuche et al. (2009); Domingos et al. (2009); Dominguez-Medina et al. (2012); Hall et al. (2007); Khatun et al. (2012); Pan et al. (2013); Patri et al. (2006); Schacher et al. (2009); Tiede et al. (2008); Wagner et al. (2007); Wang (2001); Williams and Carter (2009)
Scanning tunneling microscopy (STM) Size and size distribution
Shape
Structure
Dispersion
Aggregation
Direct measurement
High spatial resolution at atomic scale
Conductive surface required
Surface electronic structure and surface to pography unnecessarily having a simple connection
Fleming et al. (2009); Kocum et al. (2004); Nakaya et al. (2011); Ong et al. (2013); Overgaag et al. (2008); Wang and Chu (2013)
Atomic force microscopy (AFM) Size and size distribution
Shape
Structure
Sorption
Dispersion
Aggregation
Surface properties (modified AFM)
3D sample surface mapping Sub-nanoscaled topographic resolution
Direct measurement of samples in dry, aqueous or ambient environment
Overestimation of lateral dimensions
Poor sampling and time consuming
Analysis in general limited to the exterior of nanomaterials
Domingos et al. (2009); Gmoshinski et al. (2013); Mavrocordatos et al. (2004); Parot et al. (2007); Sapsford et al. (2011); Schaefer et al. (2012); Tang et al. (2010); Tiede et al. (2008); Yang et al. (2005)
Nuclear magnetic resonance (NMR) Size (indirect analysis)
Structure
Composition
Purity
Conformational change
Non-destructive/non-invasive method
Little sample preparation
Low sensitivity
Time consuming
Relatively large amount of sample required
Only certain nuclei NMR active
Lundqvist et al. (2005); Mullen et al. (2010); Pan et al. (2006); Patri et al. (2006); Tomalia et al. (2003); Valentini et al. (2004) Gun'ko et al. (2009); Mirau et al. (2011); Sapsford et al. (2011); Tang et al. (2010)
X-ray diffraction (XRD) Size, shape and structure for crystalline materials Well-established technique
High spatial resolution at atomic scale
Limited applications in crystalline materials
Only single conformation/binding state of sample accessible
Low intensity compared to electron diffraction
Caminade et al. (2005); Cao (2004); Gun'ko et al. (2009); Sapsford et al. (2011); Zak et al. (2011); Zanchet et al. (2001); Zhao et al. (2008); Zhou et al. (2012)
Small-angle X-ray scattering (SAXS) Size/size distribution
Shape
Structure
Non-destructive method
Simplification of sample preparation
Amorphous materials and sample in solution accessible
Relatively low resolution Doniach (2001); Grosso et al. (2011); Hummer et al. (2012); Rao and Biswas (2009); Sapsford et al. (2011)

2. Overview of physicochemical characteristics

Typically, engineered materials with dimensions in the nanometer scale are intermediates between isolated small molecules and bulk materials. Nanomaterials, which are similar to biological moieties in scale, can be used as diagnostic and therapeutic nanomedicines (Del Burgo et al., in press; Hachani et al., 2013; Kim et al., 2010). Compared to their bulk material counterparts, the distinct physicochemical properties of the nanomaterials, such as size, surface properties, shape, composition, molecular weight, identity, purity, stability and solubility, are critically relevant to particular physiological interactions (Table 2) (Patri et al., 2006). These physiological interactions may provide benefits in medical applications, including improvements in efficacy, reduction of side effects, prevention and treatment (Farokhzad and Langer, 2006; Hall et al., 2007).

Table 2.

Physicochemical characteristics of nanomaterials and suitable evaluation modalities.

Nanomaterial characteristics Techniques Refs
Size/size distribution DLS, FCS, RS, NSOM, SEM, TEM, STM, AFM, NMR, TOF-MS, XRD, SAXS, FS, UV–visible, AUC, GE, CE, FFF Biju et al. (2010b); Bootz et al. (2004); Braun et al. (2009); Caminade et al. (2005); Domingos et al. (2009); Hall et al. (2007); Hurst et al. (2006); Jiang et al. (2004); Mavrocordatos et al. (2004); Murdock et al. (2008); Nienhaus et al. (2013); Pan et al. (2013); Powers et al. (2006); Rao and Biswas (2009); Sapsford et al. (2011); Schacher et al. (2009); Valentini et al. (2004); Wang and Chu (2013); Zanchet et al. (2001)
Surface charge Zeta potential (ELS), ATR–FTIR, GE, CE Choi et al. (2011); Liu and Webster (2007); Sapsford et al. (2011); Xu (2008)
Shape NSOM, SEM, TEM, STM, AFM, XRD, SAXS, AUC Bootz et al. (2004); Caminade et al. (2005); Hall et al. (2007); Mavrocordatos et al. (2004); Rao and Biswas (2009); Sapsford et al. (2011); Wang and Chu (2013); Zanchet et al. (2001)
Structure TERS, CD, MS, IR, STM, AFM, RS, NMR, XRD, SAXS, FS, DSC, AUC Bothun (2008); Caminade et al. (2005); Gmoshinski et al. (2013); Grosso et al. (2011); Gun'ko et al. (2009); Mavrocordatos et al. (2004); Mirau et al. (2011); Mullen et al. (2010); Ong et al. (2013); Popovic et al. (2011); Rao and Biswas (2009); Sapsford et al. (2011); Tomalia et al. (2003); Wang and Chu (2013); Zanchet et al. (2001)
Composition MS, NMR Gmoshinski et al. (2013); Mullen et al. (2010); Tomalia et al. (2003)
Purity MS, NMR, HPLC, HDC Liu et al. (2012); Mullen et al. (2010); Patri et al. (2006); Sapsford et al. (2011); Tang et al. (2010); Tomalia et al. (2003)
Stability Zeta potential measurement, CD, TGA, DSC, ITC, thermophoresis, HPLC, HDC Bothun (2008); das Neves et al. (2010); Gugulothu and Patravale (in press); Khatun et al. (2012); Patri et al. (2006); Sapsford et al. (2011)
Dispersion ESEM, TEM, STM, AFM Bernier et al. (2012); Bootz et al. (2004); Hall et al. (2007); Mavrocordatos et al. (2004); Sapsford et al. (2011); Wang and Chu (2013)
Surface properties CD coupled with an enzyme-linked immunosorbent assay, time-of-flight secondary ion MS, ATR–FTIR, modified AFM, X-ray photoelectron spectroscopy Baer (2012); Fujie et al. (2009); Guay-Bégin et al. (2011); Liu and Webster (2007); Yang and Watts (2005)
Protein corona (thickness and density)a DLS, FCS, TEM, size exclusion chromatography, differential centrifugal sedimentation (Milani et al. (2012); Nienhaus et al. (2013); Rahman et al. (2013); Röcker et al. (2009); Walczyk et al. (2010)
Protein corona (composition and quantify)a Polyacrylamide GE, LC–MS/MS (Cedervall et al. ()2007; Kapralov et al. (2012); Milani et al. (2012); Monopoli et al. (2011); Rahman et al. (2013); Sacchetti et al. (2013)
Protein corona (conformation)a CD, simulation Gebauer et al. (2012); Laera et al. (2011); Rahman et al. (2013)
Protein corona (affinity)a Size exclusion chromatography, SPR, ITC Casals et al. (2010); Cedervall et al. (2007); Liu et al. (2013); Rahman et al. (2013); Tassa et al. (2009); Zhao et al. (2013)
a

Courtesy of Rahman et al. (2013).

Impact of nanomaterials on their physiological behaviors will influence the therapeutic efficacy and/or diagnostic accuracy of nanomedicines. In this context, it is important to understand how the different physicochemical characteristics of nanomaterials affect their in vivo distribution and behavior. This demands reliable and robust techniques for studying the different physicochemical characteristics of nanomaterials in general and nanomedicines in particular. The different techniques used for characterization of nanomaterials, based on their different features, are described in the following sections. A rigorous but practical approach to reliable characterization of nanomaterials is essential for quality assurance and safe, rational development of nanomedicines and theranostics (Akhter et al., 2013; Kim et al., 2013).

2.1. Size

In engineered nanomaterials, size is a crucial factor that regulates the circulation and navigation of nanomaterials in the bloodstream, penetration across the physiological drug barriers, site- and cell-specific localization and even induction of cellular responses (Feng, 2004; Ferrari, 2008; Jiang et al., 2008). In general, the size of a nonspherical nanomaterial is defined as an equivalent diameter of a spherical particle whose selected physical properties, e.g. diffusivity, are equivalent to those of the nanomaterial in the same environment (Powers et al., 2006; Shekunov et al., 2007). One frequently adopted example is the hydrodynamic diameter of a molecule, which is the effective size calculated from the diffusion coefficient using the Stokes–Einstein relationship (Powers et al., 2006).

Lately there has been public and government concern about the toxicity of nanomaterials and their related adverse health effects, such as pronounced pulmonary inflammation (Horváth et al., 2013; Karlsson et al., 2009; Oberdörster, 2005). Other examples include the smaller silver NPs causing a greater apoptotic effect against certain cell lines and 20 nm silica NPs exhibiting more toxicity than negatively-charged 100 nm silica NPs (Kim et al., 2012; Park et al., 2013; Sosenkova and Egorova, 2011). Although NPs with certain chemical compositions were reported to be more toxic compared to their larger counterparts of the same composition, a consensus on the increased toxicity and putative health risks of nanomaterials may not emerge due to the lack of obvious size-related change in toxicity in other NPs, e.g. titanium oxide and iron oxides (Buzea et al., 2007; Horváth et al., 2013; Karlsson et al., 2009; Park et al., 2007; Warheit et al., 2006). The relationship of size and/or shape to nanoparticle toxicity or nanomedicine efficacy has to be investigated on a case by case basis, because of the wide differences in the behavior of different nanomaterials.

2.2. Surface properties

Many characteristics of nanomaterial interfaces are functions of atomic or molecular compositions of the surfaces and the physical surface structures that respond to the interactions of the nanomaterial with surrounding species (Patri et al., 2006; Powers et al., 2006). From the aspect of nanomedicine, these characteristics are considered the elements of surface properties in the environment of biological fluid (Patri et al., 2006; Powers et al., 2006). Among the different surface properties, surface composition, surface energy, wettability, surface charge and species absorbance or adhesion are commonly considered important parameters (Brodbeck et al., 2001; Patri et al., 2006; Powers et al., 2006; Ratner et al., 2004; Vertegel et al., 2004). Surface composition is intrinsically relevant to the superficial layers but not to the bulk materials. Surface energy is relevant to the dissolution, aggregation and accumulation of nanomaterial. Surface charge, with potential effect on receptor binding and physiological barrier penetration, governs the dispersion stability or aggregation of nanomaterials and is generally estimated by zeta potential. Finally, species absorbance or adhesion potentially alters the surface of nanomaterial as well as the conformation and the activity of the attached species. However, investigation of the entire spectrum of surface parameters is impractical, and prioritization of the surface parameters requires independent validation for each nanomaterial system (Powers et al., 2006; Ratner et al., 2004).

Recent studies have shown improvement of cellular and lysosome uptakes of positively-charged nanomaterials, compared with their neutral or negatively-charged counterparts (Asati et al., 2010; Baoum et al., 2010; Klesing et al., 2010; Liu et al., 2011; Luyts et al., 2013). The enhanced uptake of positively-charged NPs makes them attractive as agents for tumor drug delivery: poly(d,l-lactide-co-glycolide)-formulated NPs with cationic chitosan are useful for localized, sustained gene delivery to the alveolar epithelium (Baoum et al., 2010). However, positively-charged nanomaterials can be more toxic than their negatively-charged counterparts. The positively-charged amino-modified polystyrene-formulated NPs were cytotoxic to certain cell lines by inducing DNA damage (Liu et al., 2011). Positively-charged branched polyethyleneimine coated Ag NPs were highly toxic to certain bacillus species in which the NPs caused membrane damage (El Badawy et al., 2010). Cytotoxicity of positively-charged Si NP-NH2 towards macrophage NR8383 cells involved effects on phagocytosis, mitochondrial disruption and the production of high levels of intracellular reactive oxygen species (Bhattacharjee et al., 2010). In contrast, the effects of surface charge on cytotoxicity and reactive oxygen species generation were enhanced in the negatively-charged silica NPs of 20 nm in size, compared with those induced by silica NPs of the same size, but weaker negative charge (Park et al., 2013). Although the connection between increased cellular uptake of positively-charged NPs and elevated cytotoxicity was typically demonstrated in in vitro studies, in vivo evidence is less convincing (Luyts et al., 2013). The relation between surface charge/zeta potential and NP toxicity cannot be generalized (Luyts et al., 2013).

2.3. Shape

In addition to size and surface properties, the shape of nanomaterial can play an important role in drug delivery, degradation, transport, targeting and internalization (Champion et al., 2007; Decuzzi et al., 2009; Euliss et al., 2006; Geng et al., 2007; Gratton et al., 2008; Jiang et al., 2013; Mitragotri, 2009). Efficiency of drug delivery carriers was highly influenced by controlling the shapes of the carriers (Champion et al., 2007; Decuzzi et al., 2009), while phagocytosis of drug delivery carriers through macrophages was also dependent on carrier shape (Champion and Mitragotri, 2009). Furthermore, flow and adhesion of drug delivery carriers throughout the circulatory system and the in vivo circulation time of the nanomedicine can be controlled by modulating the shapes of drug-loaded nanomaterials (Doshi et al., 2010; Geng et al., 2007).

The shape of nanomaterial affects cellular uptake, biocompatibility and retention in tissues and organs (George et al., 2012; Pal et al., 2007). Additionally, the disposition and translocation of nanomaterials in the organism may be influenced by their shape, accompanying size and state of agglomeration (Powers et al., 2009). One example is an in vitro study of silica NPs demonstrating shape-driven agglomeration as a potential trigger in the pulmonary pathogenesis (Brown et al., 2007). Another example is the higher toxicity of dendrimer-shaped nickel NPs compared to that of the spherical ones towards zebrafish embryos (Ispas et al., 2009). Similarly, plate-shaped silver NPs were more hazardous than spherical, rod-shaped or wire shaped silver nanoparticles when tested against Escherichia coli and zebrafish embryos (George et al., 2012; Pal et al., 2007). Furthermore, recent studies demonstrated an asbestos-like pathogenic response when carbon nanotubes of length greater than 20 µm were delivered into the abdominal cavity of mice (Kostarelos, 2008; Poland et al., 2008; Powers et al., 2009; Takagi et al., 2008).

2.4. Composition and purity

A broad variety of nanomaterials are utilized in the production of approved or potential nanomedicines. These nanomaterials can be categorized by their structural types, such as NP and its derivatives, liposome, micelle, dendrimer/fleximer, virosome, emulsion, quantum dot, fullerene, carbon nanotube and hydrogel, and each type may consist of polymers, metals and metal oxides, lipids, proteins, DNA or other organic compounds (Etheridge et al., 2013; Patri et al., 2006). Composition of a nanomaterial affects transport, delivery and biodistribution. In biomedical applications of nanomaterials, there may be a need to combine two or more types of nanomaterials to forma complex such as a chelate, a conjugant or a capsule. Consequently chemical composition analysis of the nanomaterial complex is more complicated than that for a single entity (Patri et al., 2006).

There are several studies addressing toxicological concerns about NPs of different compositions (Hardman, 2006). In addition to size and shape, chemical composition is another important factor in determining toxicity of NPs (Buzea et al., 2007; Hardman, 2006). For example, TiO2 induced an inflammatory neutrophil response when intratracheally instilled in rat and mouse lungs (Oberdörster, 2005; Sohaebuddin et al., 2010). In addition, cytotoxicity is generally observed in quantum dots with core metalloid complexes consisting of widely used metals such as cadmium and selenium (Hardman, 2006). Still, quantum dots can be rendered nontoxic, when core coatings are appropriately registered; alternatively, the cytotoxicity of quantum dots was only observed after degradation of their core coating in vivo or in vitro (Buzea et al., 2007; Derfus et al., 2003; Hardman, 2006).

The presence of pharmaceutical impurities may significantly impact drug efficacy or even introduce unfavorable side effects. In general, determination of nanomaterial purity can be accomplished through analysis of their chemical compositions. Prior to finalizing a nanomaterial's formulation and proceeding with the composition analysis, proper purification processes are required to remove any residual manufacturing components or side products to ensure the absence of endotoxin contamination (Crist et al., 2013).

2.5. Stability

Pharmaceutical stability refers to retaining the same properties for a period of time after the pharmaceutical is manufactured. Similar to conventional single-molecule pharmaceuticals, the stability of nanomedicines may be affected by one or more factors, such as temperature, moisture, solvents, pH, particle/molecular size, exposure to different types of ionizing and non-ionizing radiation, enzymatic degradation and even the presence of other excipients and impurities (Briscoe and Hage, 2009; Patri et al., 2006). The stability of nanomaterial may impact its corresponding toxicity; for instance, a number of studies have shown that quantum dot cytotoxicity might be induced during synthesis, storage or even in vivo by oxidative or photolytic degradation of quantum dots (Hardman, 2006).

2.6. Interaction between nanomaterials and biological environments

When nanomaterials are introduced into biological environments or integrated in biomaterials, many undesirable effects such as aggregation, coagulation and non-specific absorption can occur. These may be due to a variety of intermolecular interactions occurring at the interfaces of nanomaterials with biomolecules and interaction-mediating fluids (Nel et al., 2009). While the surface properties of nanomaterials in a given medium are characterized by their physicochemical properties, including chemical composition, shape, surface geometry and crystallinity, porosity, heterogeneity and hydrolytic stability, other properties, such as surface charge, dissolution, hydration, size distribution, dispersion stability, agglomeration and aggregation of nanomaterial, are mainly governed by ionic strength, pH, temperature and the presence of biological or organic macromolecules (French et al., 2009; Hull and Bowman, 2009; Nel et al., 2009; Oberdorster et al., 2005). Thus, appropriate physicochemical characterization of nanomaterials should be profiled based on different physical states of the nanomaterials, such as solution, suspension or dry powder, as well as before and after exposure to the in vitro or in vivo test environment (Hull and Bowman, 2009).

Techniques for determining the shelf life of nanomaterial formulations are essential before considering the manufacture and use of nanomedicines. For example, it is important to guard against degradation of the nanomaterials caused by moisture, oxidation and/or aggregation. In this respect, the different characterization techniques will be useful for quality assurance.

3. Modalities for physicochemical characterization

Characterization of conventional pharmaceuticals and nanomedicines is based on the evaluation of physicochemical properties such as molecular weight, identity, composition, purity, stability and solubility. Many techniques that are routinely applied for characterization of conventional pharmaceuticals can also be used for characterization of nanomedicines (Patri et al., 2006). Yet, several specific characteristics of nanomaterials such as size, surface composition, surface energy, surface charge and shape are critically important and need to be well investigated to better comprehend nanomaterials' behaviors in vivo. Addressed below are brief descriptions of modalities used to examine the specific physicochemical properties of nanomaterials, and their main strengths and limitations for nanomaterial investigation.

3.1. Near-field scanning optical microscopy (NSOM)

The far-field imaging resolution of a conventional optical microscope is limited by the diffraction phenomenon of illuminating light, which is specified by the Rayleigh criterion (Hartschuh, 2008; Heinzelmann and Pohl, 1994). While visible light is used in conventional optical microscopes, any two point sources cannot be resolved if they are spatially separated by less than approximately 200 nm (Heinzelmann and Pohl, 1994). Therefore, optical microscopy is not suitable for nanostructure investigation. NSOM is a surface probe microscopy (SPM) technique that comprises concepts from both SPM and optical microscopy to surpass the far-field resolution limit (Durig et al., 1986; Hayazawa et al., 2012). Instead of equipping an objective lens, essential in a conventional microscope, NSOM permits laser light guided in optical fiber to emit through the tip aperture at close proximity to the object (Durig et al., 1986; Hayazawa et al., 2012). While the aperture radius is smaller than the light wavelength, the light emerging from the aperture becomes evanescent in the near-field distance to the object, meaning that light field is highly confined and localized at the aperture or at the object; therefore, the spatial resolution becomes a function of the aperture size, not the diffraction limit (Hayazawa et al., 2012; Heinzelmann and Pohl, 1994).

Given the advantages of an ensemble of fluorescence and spectroscopy measurements, plus high-resolution topographic information on the surface of nanomaterials, NSOM can access not only phase contrast, polarization, fluorescence and staining that are accessible by conventional optical microscopy, but also the distribution of single molecules on the surfaces of cells and interactions in protein–NP conjugates at nano-scaled spatial resolution (Hinterdorfer et al., 2012; Ianoul and Johnston, 2007; Park et al., 2008; Song et al., 2011; Vancso et al., 2005). Some tradeoffs of implementing NSOM include lengthy scanning time for high resolution images or large specimen area, low incident light intensity hindering excitation of weak fluorescent molecules, difficulty in imaging soft materials caused by the high spring constants of the optical fibers, particularly in shear-force mode, and the ability to only image surface features (Kohli and Mittal, 2011).

3.2. Scanning electron microscopy (SEM)

In contrast to optical microscopy, which uses light sources and glass lenses to illuminate specimens to produce magnified images, electron microscopy (EM) uses beams of accelerated electrons and electrostatic or electromagnetic lenses to generate images of much higher resolution, based on the much shorter wavelengths of electrons than visible light photons. SEM is a surface imaging method in which the incident electron beam scans across the sample surface and interacts with the sample to generate signals reflecting the atomic composition and topographic detail of the specimen surface (Hall et al., 2007; Johal, 2011; Ratner et al., 2004). The incident electrons cause emissions of elastic scattering of electrons, referring to backscattered electrons, inelastic scattering of electrons named low-energy secondary electrons, and characteristic X-ray light called cathodoluminescence from the atoms on the sample surface or near-surface material (Johal, 2011). Among these emissions, detection of the secondary electrons is the most common mode in SEM and can achieve resolution smaller than 1 nm (Johal, 2011).

The size, size distribution and shape of nanomaterials can be directly acquired from SEM; however, the process of drying and contrasting samples may cause shrinkage of the specimen and alter the characteristics of the nanomaterials (Bootz et al., 2004; Hall et al., 2007). In addition, while scanned by an electron beam, many biomolecule samples that are nonconductive specimens tend to acquire charge and insufficiently deflect the electron beam, leading to imaging faults or artifacts. Coating an ultrathin layer of electrically conducting material onto the biomolecules is often required for this sample preparation procedure (Hall et al., 2007; Suzuki, 2002). Because a cryogenic freezing method is often required in EM to image surface groups attached to NPs, the size of nanomaterial cannot be investigated in physiological conditions (Hall et al., 2007). An exception is environmental SEM (ESEM), through which samples can be imaged in their natural state without modification or preparation (Sapsford et al., 2011; Tiede et al., 2008). Because the sample chamber of ESEM is operated in a low-pressure gaseous environment of 10–50 Torr and high humidity, the charging artifacts can be eliminated, and coating samples with a conductive material is no longer necessary (Tiede et al., 2008). Still, most of the EM techniques, including SEM, possess the disadvantage of a destructive sample preparation, prohibiting its analysis by other modalities (Gmoshinski et al., 2013). In addition, biased statistics of size-distribution of heterogeneous samples is unavoidable in SEM due to the small number of sample particles in the scanning region (Bootz et al., 2004).

3.3. Transmission electron microscopy (TEM)

As the most frequently used technique for characterizing nanomaterials in EM, TEM provides direct images and chemical information of nanomaterials at a spatial resolution down to the level of atomic dimensions (<1 nm) (Patri et al., 2006; Wang, 2001). In the conventional TEM mode, an incident electron beam is transmitted through a very thin foil specimen, during which the incident electrons interacting with specimen are transformed to unscattered electrons, elastically scattered electrons or inelastically scattered electrons (Williams and Carter, 2009). The magnification of TEM is mainly determined by the ratio of the distance between objective lens and the specimen and the distance between objective lens and its image plane (Williams and Carter, 2009). The scattered or unscattered electrons are focused by a series of electromagnetic lenses and then projected on a screen to generate an electron diffraction, amplitude-contrast image, a phase-contrast image or a shadow image of varying darkness according to the density of unscattered electrons (Williams and Carter, 2009).

In addition to the high spatial resolution of TEM that enhances the morphological and structural analyses of nanomaterials, a wide variety of analytical techniques can be coupled with TEM for different applications; for example, chemical analyses of electron energy loss spectroscopy and energy dispersive X-ray spectroscopy can quantitatively investigate the electronic structure and chemical composition of the nanomaterials, respectively (Patri et al., 2006; Tiede et al., 2008; Wang, 2001). Overall, both TEM and SEM can reveal the size and shape heterogeneity of nanomaterials, as well as the degrees of aggregation and dispersion. TEM has advantages over SEM in providing better spatial resolution and capability for additional analytical measurements (Hall et al., 2007). There are certain drawbacks accompanying the advantages of TEM (Williams and Carter, 2009). A significant tradeoff is that a high vacuum and thin sample section are required for electron-beam penetration in TEM measurement (Hall et al., 2007). Sample destruction and measurement in unnatural/non-physiological conditions are common to all EM techniques. In general, high-resolution EM imaging enables examination of a minute part of the specimen over a certain period of time and results in poor statistical sampling. Also, abundant artifacts are generated due to 3D specimens being probed by the 2D TEM technique in transmission view, leading to no depth sensitivity for a single TEM image. Another limitation is that specimens have to be thin enough to transmit sufficient electrons to produce images; in particular cases, the specimen thickness of less than 50 nm is required while doing high-resolution TEM or electron spectroscopy. The extensive preparation of thin specimens increases the possibility of altering sample's structure and makes TEM analysis a very time consuming process. Another big concern is that TEM specimens can be damaged or even destroyed by intense, high-voltage electron beams.

Interestingly, wet TEM can be used for determining the particle size, dispersion, aggregation/agglomeration and dynamic displacement of nanomaterials in an aqueous environment (Carlton and Ferreira, 2012; Chen and Wen, 2012; Hondow et al., 2012). In addition to adapting the function of ESEM for observing samples under partial water vapor pressure in the microscope specimen chamber, a recently developed wet scanning transmission electron microscopy (STEM) imaging system enables transmission observation of species totally submerged in a liquid phase, compared with the issues of poor contrast and possible drifting of objects occurring in the images of the top surface of the liquid using ESEM (Bogner et al., 2005; Ponce et al., 2012). Thus, the wet mode STEM permits observation in nanoscale resolution and high contrast even through several micrometers of water, without adding contrast agents and stains (Bogner et al., 2005; de Jonge and Ross, 2011).

3.4. Scanning tunneling microscopy (STM)

As the earliest developed technique in the SPM family, STM uses quantum tunneling current to generate electron density images for conductive or semiconductive surfaces and biomolecules attached on conductive substrates at the atomic scale (Albrecht et al., 1988; Avouris, 1990; Binnig and Rohrer, 1983; Miles et al., 1990). Adapting the generic principle for all SPM techniques, i.e. bringing a susceptible probe in close proximity to the surface of an object measured to monitor the reactions of the probe (Chi and Röthig, 2001), the essential components of an STM include a sharp scanning tip, an xyz-piezo scanner controlling the lateral and vertical movement of the tip, a coarse control unit positioning the tip close to the sample within the tunneling range, a vibration isolation stage and feedback regulation electronics (Wiesendanger, 1994). As the tip–sample separation is maintained in the range of 4–7 Å, a small voltage applied between the scanning tip and the surface causes tunneling of electrons by which variation of the responding current can be recorded while the tip moves across the sample in the x–y plane to generate a map of charge density (Bonnell, 2001). Alternatively, keeping the responding current unchanged by adjusting the tip height through the use of feedback electronics can generate an image of tip topography across the sample (Bonnell, 2001).

As for characterization of biomolecules using STM or EM techniques, the samples are usually embedded into a matrix to preserve their original conformations, followed by coating the samples with a thin metallic layer, such as gold, before acquiring images (Kocum et al., 2004). It is impossible to image these biomolecules in their native conditions using conventional EM techniques that usually accompany a time-consuming sample preparation procedure. STM, on the other hand, can not only diminish the disadvantages of the EM techniques but also provide an image with atomic scale resolution by, for example, using a Pt–Ir tip with a very sharp end (Kocum et al., 2004). Although the high spatial resolution of STM should benefit the characterization of nanoscale biomaterials such as size, shape, structure, and states of dispersion and aggregation, only few studies using gold or carbon as substrates have been reported (Wang and Chu, 2013). The practical obstacles are mainly due to requirements of the conductive surface of the sample and detection of the surface electronic structure (Wang and Chu, 2013). Unfortunately, most biomaterials are insulating, and a simple connection of the sample's surface electronic structure with its surface topography may not necessarily exist. Still, STM is a preferred tool for investigating conductive atomic structures of, for example, carbon nanotubes, fullerenes and graphene (Wang and Chu, 2013).

3.5. Atomic force microscopy (AFM)

Unlike STM, AFM does not require oxide-free, electrically conductive surfaces for measurement and is a SPM imaging tool consisting of a micro-machined cantilever (typically made of silicon or silicon nitride) with a sharp tip at one end to detect the deflection of the cantilever tip caused by electrostatic and van der Waals repulsion, as well as attraction between atoms at the tip and on the measured surface (Gadegaard, 2006; Hansma et al., 1988; Marti et al., 1988; Ratner et al., 2004). The oscillating cantilever then scans over the surface of specimen to generate an image with a vertical resolution of around 0.5 nm (Tiede et al., 2008; Zhu et al., 2011). Like SEM and TEM techniques, AFM can be used for investigating the size, shape, structure, sorption, dispersion and aggregation of nanomaterials — the different scanning modes employed in AFM studies include noncontact mode (also called static mode), contact mode and intermittent sample contact mode (also called dynamic mode and tapping mode) (Hinterdorfer et al., 2012; Mavrocordatos et al., 2004; Picas et al., 2012; Sapsford et al., 2011; Song et al., 2011). In addition to probing the sizes and shapes of nanomaterials under physiological conditions, AFM is capable of characterizing dynamics between nanomaterials in biological situations, such as observing the interaction of nanomaterials with supported lipid bilayers in real time, which is not achievable with current EM techniques (Patri et al., 2006).

AFM is gaining importance due to its capability for imaging biomaterials without causing appreciable damage to many types of native surfaces (Parot et al., 2007; Yang et al., 2005). The main strength of AFM is its capability to image a variety of biomaterials at the sub-nanometer scale in aqueous fluids (Parot et al., 2007). However, a major drawback is that the size of the cantilever tip is generally larger than the dimensions of the nanomaterials examined, leading to unfavorable overestimation of the lateral dimensions of the samples (Gmoshinski et al., 2013; Tiede et al., 2008). Unlike fluorescence techniques, AFM lacks the capability of detecting or locating specific molecules; however, this disadvantage has been eliminated by recent progress in single-molecule force spectroscopy with an AFM cantilever tip carrying a ligand, a cell adhesion molecule or chemical groups, which can probe or detect single functional molecules on cell surfaces (Dufrêne and Garcia-Parajo, 2012; Francius et al., 2008).

3.6. Dynamic light scattering (DLS)

Several physicochemical characteristics of nanomaterials including hydrodynamic size, shape, structure, aggregation state, and biomolecular conformation can be explored using radiation scattering techniques (Inagaki et al., 2013; Sapsford et al., 2011). DLS, one of the most popular light scattering modalities, can probe the size distribution of small particles, molecules or polymers at the scale from submicron down to one nanometer in solution or suspension using a monochromatic light source, e.g. a laser (Patri et al., 2006; Sapsford et al., 2011). The principle of DLS is to monitor the temporal fluctuation of the elastic scattering intensity of light, i.e., Rayleigh scattering, induced from the Brownian motion of the particles/molecules of a size much smaller than the incident light wavelength, at a fixed scattering angle (Brar and Verma, 2011; Sapsford et al., 2011). The intensity fluctuation trace comprises a mixture of the constructive and destructive interferences of the scattered light, through which the particle size can be derived from analysis of the motion-dependent autocorrelation function using the Stokes–Einstein equation (Brar and Verma, 2011; Pons et al., 2006b; Sapsford et al., 2011).

For physicochemical characterization of nanomaterials, the main strengths of DLS include its noninvasive manner, short experiment duration (in minutes), accuracy in determining the hydrodynamic size of monodisperse samples, and capabilities of measuring diluted samples, analyzing samples in a wide range of concentrations and detecting small amounts of higher molecular weight species, along with lower apparatus costs and more reproducible measurement than other methods (Brar and Verma, 2011; Filipe et al., 2010; Lim et al., 2013). However, the functions of DLS are impacted by several disadvantages, such as difficulty in correlating size fractions with a particular composition when certain amounts of aggregates are present, dust particles interfering in the scattering intensity, and a relatively small range of particle or molecule size (1 nm–3 µm), although the scale limitation is not really a pitfall for characterization of nanomaterials (Bootz et al., 2004; Brar and Verma, 2011; Filipe et al., 2010). In addition, DLS has limited utility for analysis of samples with heterogeneous size distributions, and resolving the dimensions of a mixed sample population varying in size less than a factor of three; moreover, DLS is unsuited to accurately measuring the sizes of non-spherical nanomaterials because spherical nature of particles is already assumed in the analysis (Bootz et al., 2004; Brar and Verma, 2011; Filipe et al., 2010; Uskokovic, 2012).

3.7. Fluorescence correlation spectroscopy (FCS)

Similar in function to DLS, which detects spontaneous intensity fluctuation caused by molecular diffusion, aggregation or interaction with respect to time, FCS can yield quantitative information such as diffusion coefficients, hydrodynamic radii, average concentrations and kinetic chemical reaction rates through autocorrelation analysis of temporal fluorescent variation by fitting an appropriate model (Krichevsky and Bonnet, 2002; Magde et al., 1972; Sapsford et al., 2011; Wu et al., 2008). Most FCS measurements to date are performed in an optimum detection volume defined by a diffraction-limited spot generated by the strongly focused light in confocal microscopy or two-photon excitation microscopy and thus, only few fluorophores within the illuminated region are excited to restrain a small number of molecules and a high amplitude of correlation function (Krichevsky and Bonnet, 2002; Petryayeva et al., 2013; Schwille, 2001).

Analysis of the binding kinetics between donor and receptor, for example, between nanoscale vesicles and peptides and between quantum dots and proteins, can be approached using FCS or its derivatives, such as a dual-color FCS that cross-correlates data from two different fluorescent channels simultaneously (Boukari and Sackett, 2008; Pons et al., 2006a; Rusu et al., 2004; Sapsford et al., 2011). One significant advantage of FCS over DLS or NMR is the requirement of only a small amount of fluorescent probe particles at sub- to nanomolar concentrations, specifically monitoring the probe particles and preventing interfering contribution from the medium, and probing nanomaterials' dimensions in a range of nanometers to hundreds of nanometers (Boukari and Sackett, 2008). However, retaining the advantages of FCS described above requires selection of a fluorophore with high extinction coefficient, high quantum yield, low singlet-to-triplet state transition probability and low photobleaching (Boukari and Sackett, 2008). Moreover, the lack of models also limits the application and accuracy of FCS. A recent development of FCS–NSOM, which can be applied for examining cell membranes, uses the evanescent axial excitation to constrain the fluorescent background from cytoplasm components in order to achieve an observation area in an order of magnitude below the diffraction limit, with a power density comparable to confocal FCS. (Francius et al., 2008; Vobornik et al., 2008).

3.8. Raman scattering (RS)

RS is a widely-used tool for structural characterization of nanomaterials and nanostructures that provides submicron spatial resolution for light-transparent material without the requirement of sample preparation, making it suitable for in situ experiments (Popovic et al., 2011). The principle of RS is to measure the inelastic scattering of photons possessing different frequencies from the incident light after interacting with electric dipoles of the molecule (Cantor and Schimmel, 1980). The process of RS results in frequency differences between the incident photons and the inelastically scattered photons associated with the characteristics of the molecular vibrational states, during which the inelastically scattered photons emitting frequencies lower than the incident photons refer to the Stokes lines in Raman spectrum and the inelastically scattered photons emitting frequencies higher than the incident photons are named Anti-Stokes lines (Cantor and Schimmel, 1980). RS is generally considered to be complementary to IR spectroscopy, i.e., vibrational modes that are Raman active should be IR inactive, and vice versa, for small symmetrical molecules, because Raman transitions result from nuclear motion modulating the polarizability of the molecules, rather than a net change in the dipole moment of the molecules (Cantor and Schimmel, 1980).

One of the major advantages of RS is that it is suitable for studying biological samples in aqueous solution because water molecules tend to be weak Raman scatterers. Furthermore, the detailed molecular information offered by RS can be used to investigate conformations and concentrations of tissue constituents, which demonstrates the potential of RS for detecting tissue abnormalities (Kumar, 2012). However, while the conventional RS technique provides indirect characterization of nanomaterials, such as average size and size distribution through analysis of the spectral line broadening and shift, it lacks the spatial resolution necessary to delineate different domains for application in nanotechnology (Kattumenu et al., 2012; Popovic et al., 2011). Other downsides of conventional RS include interference of fluorescence and extremely small cross section, demanding intense laser excitation and a large amount of sample materials to provide sufficient RS signals (Chang et al., 2012). In contrast, implementation of surface enhanced Raman scattering (SERS) can strongly enhance RS signals and increase spatial resolution while the measured biomolecules are adhered to the surface of metallic structures, such as commonly used gold or silver NP colloid substrates (Lee et al., 2013a; Lin et al., 2009; Wilson and Willets, 2013). SERS can be used to (i) study surface functionalization of metallic NPs, (ii) monitor the conformational change in proteins conjugated to the metallic NPs, and (iii) track intracellular drug release from the nanoplatform and measurement of the pH in the surrounding medium (Ando et al., 2013; Huang et al., 2013a; Kneipp et al., 2010; Kumar and Thomas, 2011; Mannelli and Marco, 2010).

By adapting the concept of confining the light field in Raman near-field scanning optical microscopy to overcome diffraction-limited resolution, a recently emerging technique, tip-enhanced Raman spectroscopy (TERS), utilizes an apertureless metallic tip instead of an optical fiber to gain the surface enhancement of the Raman signals (the SERS effect) (Ando et al., 2013; Hartschuh, 2008; Hayazawa et al., 2012; Wang and Irudayaraj, 2013). In contrast to conventional RS, SERS and TERS provide topological information of the nanomaterials, in addition to their structural, chemical and electronic properties, which conventional RS provides (Lee et al., 2013b; Popovic et al., 2011). However, the lack of measurement reproducibility in SERS caused by the size and shape variation, as well as undesirable aggregation of NPs is an obstacle for in vitro or in vivo imaging applications (Xiao et al., 2010).

3.9. Circular dichroism (CD)

Given a chiral molecule that possesses molecular asymmetry, CD is used to characterize the structure of the molecule through the different absorptions of circularly polarized lights in left-handed direction and in right-handed direction on the asymmetric molecule (Ranjbar and Gill, 2009). In the past few decades, various types of CD-based techniques have been developed to improve the capability of assessing conformational changes in proteins and nucleic acids, secondary and tertiary structures of proteins and their thermal stability, and donor–acceptor interactions, e.g. protein–protein, protein–DNA, protein–ligand and DNA–ligand interactions (Jiang et al., 2004; Ranjbar and Gill, 2009; Sapsford et al., 2011; Shang et al., 2007). In addition, the conformational behavior of biomolecules on NPs, the structures of drug-delivery nanocarriers and the interactions of nanocarriers with biomolecules have been investigated using CD techniques (Bhogale et al., 2013; Caminade et al., 2005; Ghosh et al., 2007; Liu and Webster, 2007; Ranjbar and Gill, 2009).

Although conventional CD spectroscopy is a prompt, nondestructive tool to reveal the structure and/or conformational change of the biomolecule investigated, there are several limitations of this technique. First, CD cannot manifest the actual contribution made by any particular amino-acid residue in a protein-type biomolecule to composing a CD spectrum (Ranjbar and Gill, 2009). Second, CD spectroscopy, based on differential absorption of left and right circularly polarized radiation, is less sensitive than absorption spectroscopy by two to three orders of magnitude. Third, it is challenging to analyze CD spectra acquired in a complex of a chiral compartment adhering to a chiral receptor, which is very common in biomacromolecules and nanomaterials. And finally, conventional CD measurement exhibits weak spectra if the sample contains only non-chiral chromophores. Some of the limitations can be eliminated by implementing different CD-based techniques, for example, fluorescence detected CD to enhance sensitivity, and magnetic CD to detect molecules that lack a chiral center (Kobayashi et al., 2011; Tanaka et al., 2005).

A number of CD-based techniques have been developed to improve biological structure measurements, such as electronic CD, magnetic CD (MCD), fluorescence detected CD, near-infrared CD, vibrational CD (VCD), HPLC–CD, stopped-flow CD and synchrotron radiation CD (Ranjbar and Gill, 2009). Some of these CD-based methods have been used to investigate nanomaterials in various circumstances/situations (Burgi, 2011). For example, the local characteristics of VCD spectra revealed the conformation of 1,1′-binaphthyl-2,2′-dithiol adhered to gold nanoclusters (Gautier and Bürgi, 2010). Additionally, MCD spectroscopy, which is complementary to UV–vis spectroscopy, for the gold (I) complex Au(AuPPh3)83+ in a solution phase yielded higher resolution and more features, compared with that of electronic absorption (Yao et al., 2012).

3.10. Infrared (IR) spectroscopy

Typically, a molecule may absorb IR radiation if it possesses a time-variant dipole moment and its oscillating frequency is the same as the frequency of incident IR light (Johal, 2011). The absorption of IR radiation transfers energy to the molecule, inducing a corresponding covalent bond stretching, bending or twisting, which, in the case of a normal mode, is described by a stationary state of molecular vibrational Hamiltonian (Cantor and Schimmel, 1980). Molecules without dipole moments, e.g. diatomic molecules N2 and O2, do not absorb IR radiation (Johal, 2011). Generally in a molecule, the vibrations involve various coupled pairs of atoms or covalent bonds, each of which must be considered as a combination of the normal modes; therefore, the IR spectrum, illustrating absorption or transmission versus incident IR frequency, can offer a fingerprint of the structure of the molecule of interest (Cantor and Schimmel, 1980).

For nanomaterial applications, Fourier transform infrared (FTIR) spectroscopy is commonly employed to use the expression of characteristic spectral bands to reveal nanomaterial–biomolecule conjugation, e.g. proteins bound to NP surfaces, and to illustrate the conformational states of the bound proteins (Jiang et al., 2004; Perevedentseva et al., 2010; Shang et al., 2007; Tom et al., 2006). Furthermore, FTIR has also been extended to study nano-scaled materials, such as confirmation of functional molecules covalently grafted onto carbon nanotubes (Baudot et al., 2010). A recently developed technique called attenuated total reflection (ATR)–FTIR spectroscopy uses the property of total internal reflection in conjunction with IR spectroscopy to probe the structure of adsorbed/deposited species at a solid/air or solid/liquid interface, while avoiding the drawbacks of sample preparation complexity and spectral irreproducibility in conventional IR (Hind et al., 2001; Johal, 2011). In an ATR–FTIR system, the total internal reflectance, occurring within the equipped internal reflection element (IRE) crystal, which has a high refractive index at certain angles, forms evanescent waves that extend from the IRE crystal–sample interface into the sample with penetration depth of micrometers (0.5–5 µm), and the intensity of the evanescent waves decays exponentially from the interface (Johal, 2011). ATR–FTIR can provide IR absorption spectra to investigate, for example, changes in surface properties as well as identification of chemical properties on the polymer surface when sample on the IRE–sample interface absorbs the evanescent IR waves with frequencies matching the vibrational modes of the sample (Johal, 2011; Kazarian and Chan, 2006; Liu and Webster, 2007). Although ATR–FTIR spectroscopy can be implemented to study the surface features of nanomaterials, it is not a very sensitive surface-analysis method at nanometer scale because the penetration depth of ATR–FTIR has the same order of magnitude as the incident IR wavelength (Liu and Webster, 2007).

3.11. Nuclear magnetic resonance (NMR)

In contrast to imaging and diffraction techniques affording structural information at long-range order, i.e. the crystalline property, NMR is sensitive to the local environment to resolve the structures of amorphous materials, polymers and biomolecules that lack long-range order (Wang et al., 2001). In addition to evaluating the structures and compositions of the species, NMR spectroscopy provides tools to investigate dynamic interactions of the species in different conditions (Sapsford et al., 2011; Tiede et al., 2008) — the relaxation, molecular conformation and molecular mobility can be evaluated through different dynamic measurements using specifically designed rf and/or gradient pulse sequences (Wang et al., 2001). NMR spectroscopy has been implemented to determine several physiochemical characteristics of nanomaterials, including structure, purity and functionality in dendrimers, polymers and fullerene derivatives, as well as conformational changes occurring in the interactions between ligands and nanomaterials (Lundqvist et al., 2005; Mullen et al., 2010; Pan et al., 2006; Patri et al., 2006; Tomalia et al., 2003). Pulsed field gradient NMR has been implemented to evaluate the diffusivity of nanomaterials, through which the sizes and interactions of species under investigation can be calculated (Valentini et al., 2004).

NMR is a non-destructive/noninvasive technique that requires little sample preparation. However, the low detection sensitivity of NMR, in contrast to optical techniques, requires a relatively large amount of the sample for measurement (Sapsford et al., 2011). It can also be time consuming if a certain level of signal-to-noise ratio is necessary for spectral analysis.

Over the past few years, the method using magic angle spinning for non-solid materials named high-resolution magic angle spinning (HR-MAS) NMR has been widely adapted in the biological and biomedical fields due to its capability of generating spectra similar to high-resolution NMR for investigating tissues and cells with heterogeneous nature (Alam and Jenkins, 2012). The advantage of HR-MAS NMR for accurate characterization of the surface-attached ligands and modified surfaces has been utilized for investigating each synthetic step of the cyclo-peptide immobilized on the surface of poly(vinylidene fluoride) based NPs, and studying thermolytically produced thiol-derivatized silver clusters (Alam and Jenkins, 2012; Conte et al., 2007; Deshayes et al., 2010).

3.12. Mass spectrometry (MS)

MS is one of the major analytical techniques used to examine the mass, elemental composition and chemical structure of a particle or a molecule. The basic principle of MS is to distinguish charged particles with different masses based on their mass-to-charge ratios (McNaught and Wilkinson, 1997). MS provides a high degree of precision and accuracy for molecular weight determination, as well as high detection sensitivity, which only requires 10−9 to 10−21 mol of a sample. Several physicochemical characteristics of nanomaterials, including mass, composition and structure, can be depicted using various MS procedures, distinguished by their ion sources, separation methods and detector systems (Gmoshinski et al., 2013). Among the ionization techniques coupled with MS analyzers, matrix-assisted laser desorption/ionization (MALDI) and electrospray ionization (ESI) are commonly used to ionize and volatilize the thermally-labile biomolecular derivatives instead of introducing significant fragmentation or decomposition of the molecules. Inductively coupled plasma (ICP) ionization, on the other hand, is mainly implemented in the analysis of metal-containing nanomaterials (Gmoshinski et al., 2013; Tiede et al., 2008). Applications of different MS procedures for nanomaterials include using time of flight (TOF)-MS to determine the size/size distribution of nanomaterials (Powers et al., 2006), MALDI–TOF-MS to measure the molecular weights of macromolecules, polymers and dendrimers as well as to illustrate proteins binding to NPs (Patri et al., 2006; Tom et al., 2006), ICP-MS to validate the conjugation reaction of a functionalized NP with a modified contrast agent (Endres et al., 2007), and secondary ion MS to access the elemental and molecular properties of the top layer of NPs, as well as to examine biomaterial surface properties in physiological conditions (Guo et al., 2006; Ratner et al., 2004). Although these MS techniques have been applied to the analysis of physicochemical properties of various biomolecules, the currently incomplete MS spectral databases still cause difficulty in identifying molecular species, for example, in the analysis of MALDI–TOF-MS outcome measures (Lavigne et al., 2013). Additionally, the applications of MS techniques for nanomaterials to date are constrained in nanomateril-bioconjugate characterization, mainly due to the cost of instrumentation, sample destruction and necessary instruments generally supplied for other investigations (Sapsford et al., 2011).

3.13. Zeta potential

In an ionic solution, the surface of a charged particle is firmly bound to opposite charged ions, forming a thin liquid layer named the Stern layer, which is encompassed by an outer diffuse layer consisting of loosely associated ions. These two layers compose the so-called electrical double layer (Clogston and Patri, 2011). Given the tangential motion driven by an external force or Brownian motion of the charged particle, the movement of the charged particle shears ions migrating with the charge particle in the diffuse layer from ions staying with the bulk dispersant outside the layer (Clogston and Patri, 2011). The electric potential on the shear surface is called zeta potential, which is usually determined by measuring the velocity of the charged species towards the electrode in the presence of an external electric field across the sample solution (Pons et al., 2006b; Sapsford et al., 2011). The zeta potential with a value of ± 30 mV is generally chosen to infer particle stability, through which the absolute value greater than 30 mV indicates a stable condition, whereas a low zeta potential value of less than 30 mV indicates a condition towards instability, aggregation, coagulation or flocculation (Sapsford et al., 2011).

Among the methods of evaluating zeta potential, the technique of electrophoretic light scattering (ELS), which can simultaneously measure the velocities of many charged particles in liquid, is most commonly used (Doane et al., 2011; Xu, 2008). However, it still suffers the electro-osmotic effect that reduces precision and reproducibility of the measurement (Weiner et al., 1993). Although measuring the zeta potential of suspended particles after dilution reduces difficulty of light penetration into the sample solution, it is worth noting that zeta potential is a property sensitive to environmental changes including pH and ionic strength (Weiner et al., 1993; Xu, 2008). Therefore, a precise, repeatable zeta potential measurement in a diluted solution cannot reflect the true value in a concentrated suspension (Xu, 2008).

3.14. X-ray diffraction (XRD)

In a variety of X-ray spectroscopic modalities, XRD is a primary tool for completely resolving the tertiary structures of crystalline materials at the atomic scale (Cantor and Schimmel, 1980; Sapsford et al., 2011). The diffraction of X-ray can be simply described as the reflection of a collimated beam of X-rays incident on the crystalline planes of an examined specimen according to Bragg's law (Cantor and Schimmel, 1980). Typically, XRD, based on wide-angle elastic scattering of X-rays, is a tool for characterizing crystalline size, shape and lattice distortion by long-range order, but is limited to disordered materials (Caminade et al., 2005; Sapsford et al., 2011; Zanchet et al., 2001).

Although XRD is a well-established technique and has frequently been used to determine the material structure at the atomic scale, difficulty in growing crystals and the ability of getting results only from single conformation/binding state of the sample limit the applications of XRD technique (Cao, 2004; Sapsford et al., 2011; Zanchet et al., 2001). Another disadvantage of XRD is the low intensity of diffracted X-rays, particularly for low atomic number materials, compared with electron diffractions (Cao, 2004). A recent X-ray diffraction study reported a new approach using femtosecond pulses from a hard-X-ray free-electron laser for structure determination, which may benefit structure determination of macromolecules that do not yield sufficient crystal size for using conventional radiation sources or are not sensitive to radiation damage (Chapman et al., 2011).

3.15. Small-angle X-ray scattering (SAXS)

In contrast to XRD, whose applications are limited to crystalline materials, SAXS provides information of several characteristics by examining either crystalline or amorphous materials from polymers, proteins to nanomaterials (Lipfert and Doniach, 2007; Rao and Biswas, 2009; Sapsford et al., 2011). In SAXS, a portion of an incident X-ray beam elastically scattered from the sample forms a scattering pattern on a two-dimensional flat X-ray detector perpendicular to the direction of the incident X-ray beam (Doniach, 2001; Rao and Biswas, 2009; Sapsford et al., 2011). By analyzing the intensity of the scattered X-ray collected within the scattering angle, ranging from 0.1 to 3°, SAXS can evaluate the size/size distribution, shape, orientation, and structure of a variety of polymers and nanomaterial-bioconjugate systems in solution (Doniach, 2001; Rao and Biswas, 2009; Sapsford et al., 2011).

The features of small-angle scattering in SAXS lead to the capability of studying non-repeating structures; therefore, perfect crystallized structures are not required, which simplifies sample preparation and makes SAXS a non-destructive method (Rao and Biswas, 2009). On the other hand, SAX measurements provide holistic information about the structure, which exhibits the averaged characteristics rather than local probes of individual grains (Rao and Biswas, 2009). This feature can be a disadvantage if high resolution is required. On the other hand, recent progress in SAXS can achieve higher resolution measurements by introducing synchrotron as the high-energy X-ray source (Petoukhov and Svergun, 2013; Rao and Biswas, 2009).

Other X-ray spectroscopic techniques, such as X-ray absorption spectroscopy, can yield information about chemical state and symmetries of the absorption site through analysis of the X-ray absorption near edge structure spectra, and provide structural information, including coordination numbers and inter-atomic distance to ligands and neighboring atoms from the absorbing element through investigation of the spectra of extended X-ray absorption fine structure (EXAFS) without the requirement of long-range order in the measured species (Koningsberger and Prins, 1988; Zanchet et al., 2001). Both XRD and EXAFS can provide the averaged structural information of a nanomaterial, resulting from a long-range order and a local order of samples examined, in the manner of elastic and inelastic X-ray interaction with the samples, respectively (Zanchet et al., 2001).

4. Other techniques

Many other commonly used spectroscopic techniques for investigating the physicochemical characteristics of nanomaterials have not been listed above. One such sample is the use of UV–visible absorbance spectroscopy to investigate the characteristics of nanomaterials including size, concentration, aggregation state and even bioconjugation when the absorption profiles of nanomaterials are distinct (Biju et al., 2010b; Jiang et al., 2004; Sapsford et al., 2011). Fluorescence spectroscopy (FS), in general, is a more effective technique for pursuing the ligand binding or conformational changes of macromolecules than CD and light absorption techniques due to its sensitivity to the environment of the chromophore, as a consequence of the targeted molecular electron remaining in the excited singlet state for a relatively long duration before de-excitation (Cantor and Schimmel, 1980). Furthermore, conjugation of an extrinsic fluorophore to the non-intrinsically fluorescent nanomaterials enables FS to determine the characteristics of biomolecule on the NP surface, including concentration, particle size, and spacer composition (Hurst et al., 2006).

The thermal stability and the amount of the nanomaterial conjugates can be evaluated using several thermal techniques (Sapsford et al., 2011). The temperature-dependent weight change in bulk samples, such as various nanomaterial bioconjugates, can be monitored using thermal gravimetric analysis (TGA) (Gibson et al., 2007; Vaiyapuri et al., 2012). Material transitions such as melting, crystallization, glass transition and decomposition of nanomaterial-bioconjugates can be accessed through differential scanning calorimetry (DSC); therefore, subsequent analysis of DSC measurements can provide the structure and stability of the investigated material (Bothun, 2008). In addition, the stoichiometry, affinity and enthalpy derived from the interaction between nanomaterial and biomolecule can be determined using isothermal titration calorimetry (ITC) (Cedervall et al., 2007). By locally heating the sample to generate a temperature gradient, thermophoresis monitors the motion of the sample to evaluate its size and surface potential (Sapsford et al., 2011; Sperling et al., 2007). However, thermophoresis needs higher concentrations of the examined species than FCS does to ensure robust signals.

Several separation techniques are routinely used as characterization tools. Centrifugation, of course, is a conventional methodology of separating and purifying mixed materials. In the category of centrifugation techniques, analytical ultracentrifugation (AUC) can be implemented to investigate the conformation, structure, stoichiometry and self-aggregation state of nanomaterials, in addition to determining the size/size distribution, shape and molecular weight (Inagaki et al., 2013; Sapsford et al., 2011; Schaefer et al., 2012). While coupled with reverse-phase, ion-exchange-phase or size-exclusion-phase columns, the chromatography techniques, such as high-performance liquid chromatography (HPLC) and hydrodynamic chromatography (HDC), can be used for the purification of nanomaterial bioconjugates. Owning the capability of differentiating different nanomaterial bioconjugates, these chromatography techniques can exhibit the distribution of nanomaterial-to-biomolecule ratios, as well as the stability and purity of the post-products (Patri et al., 2006; Sapsford et al., 2011). Methods of electrophoresis are routinely used to partition and purify biomolecules, and gel electrophoresis (GE) and capillary electrophoresis (CE), for example, can further provide the relative and absolute hydrodynamic size and zeta potential of nanomaterials (Sapsford et al., 2011). Field flow fractionation (FFF), which utilizes an external field such as flow, thermal, electrical and magnetic fields applied to a fluid suspension or solution to separate the particles present in the fluid, has been implemented to reveal the size/size distribution and charge information of the investigated nanomaterials (Sapsford et al., 2011). Sedimentation and flow FFF can exhibit the effective mass, hydrodynamic size, density and volume of the nanomaterials investigated.

5. Characterization of nanomaterials

Nanomaterials commonly consist of at least two of the following units: metallic, semiconducting and organic particles or molecules (Kim et al., 2010). Additionally, nanomaterials are generally coated with polymers or biorecognition molecules to improve biocompatibility and selective targeting of biologic molecules (Kim et al., 2010). A common feature of all nanomaterials is their large ratio of surface area to volume, which may be orders of magnitude greater than that of macroscopic materials. Still, the final size and structure of nanomaterials depend on the salt and surfactant additives, reactant concentrations, reaction temperatures, and solvent conditions used during their synthesis. Stated thus, comprehension of these physicochemical properties as well as the fundamentals of the associated measuring methods is necessary before characterizing nanomaterials and developing reproducible synthesis procedures to optimize the medical application of nanomaterials.

Some nanomaterials that are nanomedicines or considered to be potential nanomedicines are generally split into several categories based on the types of nanomaterials or the application areas, such as drug delivery, drugs and therapies, in vivo imaging, in vitro diagnostics, biomaterials and implants (Wagner et al., 2008). Regardless of what criterion is used to categorize these nanomaterials, they share a certain degree of commonality in their physicochemical characteristics within and across the categories, and the same characteristics in different nanomaterials can be visualized through the use of the same or equivalent techniques described above.

Nano-drug delivery systems aim to optimize bioavailability at particular locations over a period of time, minimizing drug toxicity, increasing drug-therapeutic index and replacing invasive administration routes with non-invasive ones (Goldberg et al., 2007; Wagner et al., 2008). Nano-drug delivery systems include liposomes, nanosuspensions, NPs, dendrimers, fullerenes, and carbon nanotubes and the drug carriers in nano-drug delivery systems can be devised by regulating the composition, size, shape and morphology (Goldberg et al., 2007; Wagner et al., 2008). In a nano-drug delivery system, the system size can influence bioavailability and circulation time in blood stream, partly resulting from the impact of surface area-to-volume ratios on the solubility of the drug delivery systems (Goldberg et al., 2007; Rabinow, 2004; Vinogradov et al., 2002). Studies showed that 10–100 nm is an optimal size for nano-drug delivery systems to mostly avoid rapid removal through extravasation or through phagocytosis (Stolnik et al., 1995; Vinogradov et al., 2002). Recent studies have demonstrated that the shape of the drug carrier plays an important role in biodistribution and cellular uptake as well as avoiding phagocytosis and prolonging circulation in blood stream (Champion and Mitragotri, 2009; Geng et al., 2007). In addition, it has been reported that the surface charge of a nano-drug delivery system affects the pharmacokinetics of drugs entrapped/adhered (Hathout et al., 2007; Law et al., 2000), while the structural difference of the delivery systems may influence drug delivery efficiency (Inokuchi et al., 2010). Among the techniques described in this article for physicochemical characterization, DLS, FCS, RS, NSOM, SEM, TEM, STM, AFM, NMR, XRD, SAXS, FS and several separation techniques are suitable for evaluating the size and size distribution of nano-drug delivery systems. NSOM, SEM, TEM, STM, AFM, XRD and SAXS are proper modalities for shape measurement, while appropriate methods for surface charge measurement include zeta potential measurement (ELS), ATR–FTIR, GE and CE. In addition, TERS, CD, MS, IR, STM, AFM, NMR, XRD, SAXS, FS and some of the thermal and separation techniques can investigate the structural properties of the nanomaterials.

Along with the development of nano-drug carriers, certain types of nanomaterials have been used to design active pharmaceuticals, such as a dendrimer-derived microbiocide for preventing HIV infections and fullerenes for binding and scavenging or inactivating free radicals, which are associated with the induction of neural and cardiovascular diseases (Wagner et al., 2008). Super-paramagnetic iron-oxide NPs coated with aminosilane, for example, can be used in hyperthermia treatment of cancer by subjecting the tumor tissue to high temperatures in order to destroy neoplastic cells (Wagner et al., 2008). Magnetic NPs bound to antibodies can be specific to certain targets, e.g., stem cells, and allow sorting via magnetic field for cell therapy (Wagner et al., 2008). In addition to the physicochemical properties, including size, shape, surface charge and structure mentioned already, the stability, particularly thermal stability, of the nanomaterials plays a crucial role if nano-drugs and nano-formulations are to retain and exert consistent therapeutic efficacy. In this article, the modalities capable of characterizing the stability of nanomaterials are zeta potential measurement, CD, HPLC, HDC and several thermal techniques including TGA, DSC, ITC and thermophoresis.

Molecular diagnostics is aimed at diagnosing disease at a molecular level before symptoms manifest (Wagner et al., 2008). Compared with conventional molecular imaging agents, employment of nanomaterial-based contrast agents generally increases the signal intensity of a single particle (Rosenblum et al., 2010; Thomas et al., 2013). The strong signal generated by the nanomaterial-based contrast agents, in fact, helps overcome the essential disadvantages of low sensitivity in MRI and limited depth penetration of optical imaging to a certain degree (Lam et al., 2013; Rosenblum et al., 2010; Thomas et al., 2013). Given the novel properties of nanomaterials, several distinct nanomaterials are commonly designed as nanoscale imaging probes, including quantum dots with specific electronic and optical properties, upconversion phosphors consisting of phosphor nanocrystals doped with rare earth metals, and super-paramagnetic iron oxide particles containing an iron oxide core of magnetite and/or maghemite encased in polysaccharide, synthetic polymer or monomer coatings, or other soft materials like dendrimers (Biju et al., 2010a; Liang et al., 2008; Rosenblum et al., 2010; Wang et al., 2011). In addition to the characteristics of conventional imaging probes, such as structure, purity and solubility, certain physicochemical properties of nanomaterial-based imaging contrast agents also have to be considered, including size, shape, composition, zeta potential and dispersion (Leung et al., 2012). Techniques that can characterize the property of purity include NMR, HPLC and HDC, while the property of composition can be characterized by MS and NMR. Furthermore, the EM- and SPM-derived techniques, such as ESEM, TEM, STM and AFM, can be implemented to characterize the dispersion of nano-based imaging probes.

Even in vivo nanomaterial-based imaging contrast agents are continuously under development, nanomaterial toxicity in the body has not been comprehensively studied (Chi et al., 2012). While toxicity of being a minor concern leads to various types of nanomaterials widely used in the context of in vitro diagnostics (Chi et al., 2012), the applications of in vitro diagnostics have attracted a large amount of research interests, mainly split into NP-based biomarkers and novel sensor platforms composed of nanomaterials (Chi et al., 2012; Wagner et al., 2008). Among the physicochemical characteristics, stability is a key property in the applications of biomarkers. An example is the complete replacement of organic dyes with inorganic fluorescent NPs because organic dyes in polymerase chain reaction assays and in biochips are not photostable (Chi et al., 2012; Wagner et al., 2008). While biochips with a nano-based electrical detection system are the most popular development in the field of nano-sensor platforms, the surface chemistry properties play an important role in determining the capabilities of the biochips (Chi et al., 2012; Wagner et al., 2008).

Compared to drug delivery studies, the developments of nanoscale biomaterials and implants are still in their infancy. Still, nanomaterials have been used in a wide spectrum of applications, including tissue regeneration and medical implants (Liu and Webster, 2007; Wagner et al., 2008). Nanomaterials have been considered for a variety of implant applications, such as bone substitute materials, cartilage regeneration, vascular graft endothelialization, bladder replacement, dental restoratives, neural prostheses and antibiotic materials (Liu and Webster, 2007; Wagner et al., 2008). Among the physicochemical characteristics, surface properties are of the greatest importance to understand protein-mediated cell responses since the unique surface properties of the nanomaterials can influence interactions with proteins attached to selected cell membrane receptors (Liu and Webster, 2007). Techniques that can provide surface chemical characterization and investigation of protein–nanomaterial interactions include CD coupled with an enzyme-linked immunosorbent assay, time-of-flight secondary ion MS, ATR–FTIR, modified AFM and X-ray photoelectron spectroscopy (Liu and Webster, 2007).

Protein corona is formed in a dynamic, competitive process during which proteins or enzymes present in the biological fluid adhere to the surface of nanomaterials to generate a bio-nano interface (Luyts et al., 2013; Mahmoudi et al., 2011; Nel et al., 2009). The physicochemical properties of nanomaterials influenced by protein corona include surface properties, aggregation properties and hydrodynamic size charge; in the meantime, the adhered proteins can endure conformational alternation, functionality changes, unmasking of new epitopes and alternations in avidity and affinity effects (Cedervall et al., 2007; Luyts et al., 2013; Nel et al., 2009). In contrast to using centrifugation, a conventional method that likely disturbs protein–NP complexes, a number of methodologies, including size-exclusion chromatography gel filtration, ITC, surface plasmon resonance (SPR), have been proposed for measuring dynamic and equilibrium parameters of the protein–NP interactions and estimating the potential of NP-associated risks (Cedervall et al., 2007; Dahlin et al., 2013).

6. Conclusion

Given the novelty of physicochemical characteristics at the nanometer scale, nanomaterials have potential to impact physiological interactions from the molecular level to the systemic level, making the in vivo administration of nanomedicines an interesting research topic. The rapid development and production of nanomaterials for use as nanomedicines indicate the demand and wisdom for regulating the manufacture and use of nanomaterials. Robust techniques for characterization of nanomaterials are fundamental to regulatory guidelines for ensuring safety of nanomaterials in general and nanomedicines in particular. This article describes the essential physicochemical properties of nanomaterials, followed by an introduction to different methods that are commonly used for characterizing nanomaterials. Indeed, it is necessary to characterize the nanomaterial intended for therapeutic use in both its originally manufactured condition and after introduction into a physiological environment. The brief description of each technique, together with its strengths and limitations, provides us with a picture for selecting suitable techniques for characterization of a potential nanomedicine.

Acknowledgments

This work was supported in part by NIH/National Institute of Minority Health Disparities G12 MD007597, and US Army Medical Research and Material Command W81XWH-10-1-0767 grants.

References

  1. Akhter S, Ahmad I, Ahmad MZ, Ramazani F, Singh A, Rahman Z, et al. Nanomedicines as cancer therapeutics: current status. Curr Cancer Drug Targets. 2013;13:362–378. doi: 10.2174/1568009611313040002. [DOI] [PubMed] [Google Scholar]
  2. Alam T, Jenkins J. HR-MAS NMR spectroscopy in material science. In: Farrukh M, editor. Advanced aspects of spectroscopy. Intech Open. 2012. [Google Scholar]
  3. Albrecht TR, Dovek MM, Lang CA, GrUtter P, Quate CF, Kuan SWJ, et al. Imaging and modification of polymers by scanning tunneling and atomic force microscopy. J Appl Phys. 1988;64:1178–1184. [Google Scholar]
  4. Ando J, Yano TA, Fujita K, Kawata S. Metal nanoparticles for nano-imaging and nano-analysis. Phys Chem Chem Phys. 2013;15:13713–13722. doi: 10.1039/c3cp51806j. [DOI] [PubMed] [Google Scholar]
  5. Asati A, Santra S, Kaittanis C, Perez JM. Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano. 2010;4:5321–5331. doi: 10.1021/nn100816s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Avouris P. Atom-resolved surface chemistry using the scanning tunneling microscope. J Phys Chem. 1990;94:2246–2256. doi: 10.1103/PhysRevLett.60.1049. [DOI] [PubMed] [Google Scholar]
  7. Baer DR. Application of surface analysis methods to nanomaterials: summary of ISO/TC 201 technical report: ISO 14187:2011 – surface chemical analysis – characterization of nanomaterials. Surf Interface Anal. 2012;44:1305–1308. [Google Scholar]
  8. Baoum A, Dhillon N, Buch S, Berkland C. Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells. J Pharm Sci. 2010;99:2413–2422. doi: 10.1002/jps.21994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Baudot C, Tan CM, Kong JC. FTIR spectroscopy as a tool for nano-material characterization. Infrared Phys Technol. 2010;53:434–438. [Google Scholar]
  10. Bernier M-C, Besse M, Vayssade M, Morandat S, El Kirat K. Titaniumdioxide nanoparticles disturb the fibronectin-mediated adhesion and spreading of pre-osteoblastic cells. Langmuir. 2012;28:13660–13667. doi: 10.1021/la302219v. [DOI] [PubMed] [Google Scholar]
  11. Bhattacharjee S, de Haan L, Evers N, Jiang X, Marcelis A, Zuilhof H, et al. Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells. Part Fibre Toxicol. 2010;7:25. doi: 10.1186/1743-8977-7-25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bhogale A, Patel N, Mariam J, Dongre PM, Miotello A, Kothari DC. Comprehensive studies on the interaction of copper nanoparticles with bovine serum albumin using various spectroscopies. Colloids Surf B Biointerfaces. 2013;113C:276–284. doi: 10.1016/j.colsurfb.2013.09.021. [DOI] [PubMed] [Google Scholar]
  13. Biju V, Itoh T, Ishikawa M. Delivering quantum dots to cells: bioconjugated quantumdots for targeted and nonspecific extracellular and intracellular imaging. Chem Soc Rev. 2010a;39:3031–3056. doi: 10.1039/b926512k. [DOI] [PubMed] [Google Scholar]
  14. Biju V, Mundayoor S, Omkumar RV, Anas A, Ishikawa M. Bioconjugated quantum dots for cancer research: present status, prospects and remaining issues. Biotechnol Adv. 2010b;28:199–213. doi: 10.1016/j.biotechadv.2009.11.007. [DOI] [PubMed] [Google Scholar]
  15. Binnig G, Rohrer H. Scanning tunneling microscopy. Surf Sci. 1983;126:236–244. [Google Scholar]
  16. Bogner A, Thollet G, Basset D, Jouneau PH, Gauthier C. Wet STEM: a new development in environmental SEM for imaging nano-objects included in a liquid phase. Ultramicroscopy. 2005;104:290–301. doi: 10.1016/j.ultramic.2005.05.005. [DOI] [PubMed] [Google Scholar]
  17. Boguslavsky Y, Fadida T, Talyosef Y, Lellouche J-P. Controlling the wettability properties of polyester fibers using grafted functional nanomaterials. J Mater Chem. 2011;21:10304–10310. [Google Scholar]
  18. Bonnell D. Scanning probemicroscopy and spectroscopy: theory, techniques, and applications. Wiley-vch; 2001. [Google Scholar]
  19. Bootz A, Vogel V, Schubert D, Kreuter J. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles. Eur J Pharm Biopharm. 2004;57:369–375. doi: 10.1016/S0939-6411(03)00193-0. [DOI] [PubMed] [Google Scholar]
  20. Bothun GD. Hydrophobic silver nanoparticles trapped in lipid bilayers: size distribution, bilayer phase behavior, and optical properties. J Nanobiotechnol. 2008;6:13. doi: 10.1186/1477-3155-6-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Boukari H, Sackett DL. Fluorescence correlation spectroscopy and its application to the characterization of molecular properties and interactions. Methods Cell Biol. 2008;84:659–678. doi: 10.1016/S0091-679X(07)84021-0. [DOI] [PubMed] [Google Scholar]
  22. Brar SK, Verma M. Measurement of nanoparticles by light-scattering techniques. TrAC Trends Anal Chem. 2011;30:4–17. [Google Scholar]
  23. Braun GB, Lee SJ, Laurence T, Fera N, Fabris L, Bazan GC, et al. Generalized approach to SERS-active nanomaterials via controlled nanoparticle linking, polymer encapsulation, and small-molecule infusion. J Phys Chem C. 2009;113:13622–13629. [Google Scholar]
  24. Briscoe CJ, Hage DS. Factors affecting the stability of drugs and drug metabolites in biological matrices. Bioanalysis. 2009;1:205–220. doi: 10.4155/bio.09.20. [DOI] [PubMed] [Google Scholar]
  25. Brodbeck WG, Shive MS, Colton E, Nakayama Y, Matsuda T, Anderson JM. Influence of biomaterial surface chemistry on the apoptosis of adherent cells. J Biomed Mater Res. 2001;55:661–668. doi: 10.1002/1097-4636(20010615)55:4<661::aid-jbm1061>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  26. Brown SC, Kamal M, Nasreen N, Baumuratov A, Sharma P, Antony VB, et al. Influence of shape, adhesion and simulated lung mechanics on amorphous silica nanoparticle toxicity. Adv Powder Technol. 2007;18:69–79. [Google Scholar]
  27. Burgi T. Shining light at working interfaces and chiral nanoparticles. Chim (Aarau) 2011;65:157–167. doi: 10.2533/chimia.2011.157. [DOI] [PubMed] [Google Scholar]
  28. Buzea C, Pacheco I, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007;2:MR17–MR71. doi: 10.1116/1.2815690. [DOI] [PubMed] [Google Scholar]
  29. Caminade A-M, Laurent R, Majoral J-P. Characterization of dendrimers. Adv Drug Deliv Rev. 2005;57:2130–2146. doi: 10.1016/j.addr.2005.09.011. [DOI] [PubMed] [Google Scholar]
  30. Cantor CR, Schimmel PR. Techniques for the study of biological structure and function. San Francisco: W. H. Freeman; 1980. [Google Scholar]
  31. Cao G. Nanostructures and nanomaterials: synthe. Imperial College Press; 2004. [Google Scholar]
  32. Carlton CE, Ferreira PJ. In situ TEM nanoindentation of nanoparticles. Micron. 2012;43:1134–1139. doi: 10.1016/j.micron.2012.03.002. [DOI] [PubMed] [Google Scholar]
  33. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V. Time evolution of the nanoparticle protein corona. ACS Nano. 2010;4:3623–3632. doi: 10.1021/nn901372t. [DOI] [PubMed] [Google Scholar]
  34. Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci. 2007;104:2050–2055. doi: 10.1073/pnas.0608582104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Champion JA, Mitragotri S. Shape induced inhibition of phagocytosis of polymer particles. Pharm Res. 2009;26:244–249. doi: 10.1007/s11095-008-9626-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Champion JA, Katare YK, Mitragotri S. Particle shape: a new design parameter for microand nanoscale drug delivery carriers. J Control Release. 2007;121:3–9. doi: 10.1016/j.jconrel.2007.03.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Chang H-W, Hsu P-C, Tsai Y-C. Ag/carbon nanotubes for surface-enhanced Raman scattering. In: Kumar CSR, editor. Raman spectroscopy for nanomaterials characterization. Berlin Heidelberg: Springer; 2012. pp. 119–135. [Google Scholar]
  38. Chapman HN, Fromme P, Barty A, White TA, Kirian RA, Aquila A, et al. Femtosecond X-ray protein nanocrystallography. Nature. 2011;470:73–77. doi: 10.1038/nature09750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Chen X, Wen J. In situ wet-cell TEM observation of gold nanoparticle motion in an aqueous solution. Nanoscale Res Lett. 2012;7:1–6. doi: 10.1186/1556-276X-7-598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Chi L, Röthig C. Characterization of nanophase materials. Wiley-VCH Verlag: GmbH; 2001. Scanning probe microscopy of nanoclusters; pp. 133–163. [Google Scholar]
  41. Chi X, Huang D, Zhao Z, Zhou Z, Yin Z, Gao J. Nanoprobes for in vitro diagnostics of cancer and infectious diseases. Biomaterials. 2012;33:189–206. doi: 10.1016/j.biomaterials.2011.09.032. [DOI] [PubMed] [Google Scholar]
  42. Choi J, Reipa V, Hitchins VM, Goering PL, Malinauskas RA. Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci. 2011;123:133–143. doi: 10.1093/toxsci/kfr149. [DOI] [PubMed] [Google Scholar]
  43. Clogston J, Patri A. Zeta potential measurement. In: McNeil SE, editor. Characterization of nanoparticles intended for drug delivery. Humana Press; 2011. pp. 63–70. [Google Scholar]
  44. Conte P, Carotenuto G, Piccolo A, Perlo P, Nicolais L. NMR-investigation of the mechanism of silver mercaptide thermolysis in amorphous polystyrene. J Mater Chem. 2007;17:201–205. [Google Scholar]
  45. Crist RM, Grossman JH, Patri AK, Stern ST, Dobrovolskaia MA, Adiseshaiah PP, et al. Common pitfalls in nanotechnology: lessons learned from NCI's nanotechnology characterization laboratory. Integr Biol (Camb) 2013;5:66–73. doi: 10.1039/c2ib20117h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Cuche A, Masenelli B, Ledoux G, Amans D, Dujardin C, Sonnefraud Y, et al. Fluorescent oxide nanoparticles adapted to active tips for near-field optics. Nanotechnology. 2009;20:015603. doi: 10.1088/0957-4484/20/1/015603. [DOI] [PubMed] [Google Scholar]
  47. Dahlin AB, Wittenberg NJ, Hook F, Oh SH. Promises and challenges of nanoplasmonic devices for refractometric biosensing. Nanophotonics. 2013;2:83–101. doi: 10.1515/nanoph-2012-0026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. das Neves J, Sarmento B, Amiji MM, Bahia MF. Development and validation of a rapid reversed-phase HPLC method for the determination of the non-nucleoside reverse transcriptase inhibitor dapivirine from polymeric nanoparticles. J Pharm Biomed Anal. 2010;52:167–172. doi: 10.1016/j.jpba.2010.01.007. [DOI] [PubMed] [Google Scholar]
  49. de Jonge N, Ross FM. Electron microscopy of specimens in liquid. Nat Nanotechnol. 2011;6:695–704. doi: 10.1038/nnano.2011.161. [DOI] [PubMed] [Google Scholar]
  50. Decuzzi P, Pasqualini R, Arap W, Ferrari M. Intravascular delivery of particulate systems: does geometry really matter? Pharm Res. 2009;26:235–243. doi: 10.1007/s11095-008-9697-x. [DOI] [PubMed] [Google Scholar]
  51. Del Burgo LS, Hernandez RM, Orive G, Pedraz JL. Nanotherapeutic approaches for brain cancer management. Nanomedicine. 2013 doi: 10.1016/j.nano.2013.10.001. http://dx.doi.org/10.1016/j.nano.2013.10.001. (in press). [DOI] [PubMed] [Google Scholar]
  52. Derfus AM, Chan WCW, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 2003;4:11–18. doi: 10.1021/nl0347334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Deshayes S, Maurizot V, Clochard M-C, Berthelot T, Baudin C, Déléris G. Synthesis of specific nanoparticles for targeting tumor angiogenesis using electron-beam irradiation. Radiat Phys Chem. 2010;79:208–213. [Google Scholar]
  54. Doane TL, Chuang C-H, Hill RJ, Burda C. Nanoparticle ζ-potentials. Acc Chem Res. 2011;45:317–326. doi: 10.1021/ar200113c. [DOI] [PubMed] [Google Scholar]
  55. Domingos RF, Baalousha MA, Ju-Nam Y, Reid MM, Tufenkji N, Lead JR, et al. Characterizing manufactured nanoparticles in the environment: multimethod determination of particle sizes. Environ Sci Technol. 2009;43:7277–7284. doi: 10.1021/es900249m. [DOI] [PubMed] [Google Scholar]
  56. Dominguez-Medina S, McDonough S, Swanglap P, Landes CF, Link S. In situ measurement of bovine serum albumin interaction with gold nanospheres. Langmuir. 2012;28:9131–9139. doi: 10.1021/la3005213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Doniach S. Changes in biomolecular conformation seen by small angle X-ray scattering. Chem Rev. 2001;101:1763–1778. doi: 10.1021/cr990071k. [DOI] [PubMed] [Google Scholar]
  58. Doshi N, Prabhakarpandian B, Rea-Ramsey A, Pant K, Sundaram S, Mitragotri S. Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. J Control Release. 2010;146:196–200. doi: 10.1016/j.jconrel.2010.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Dufrêne YF, Garcia-Parajo MF. Recent progress in cell surface nanoscopy: light and force in the near-field. Nano Today. 2012;7:390–403. [Google Scholar]
  60. Duncan R, Gaspar R. Nanomedicine(s) under the microscope. Mol Pharm. 2011;8:2101–2141. doi: 10.1021/mp200394t. [DOI] [PubMed] [Google Scholar]
  61. Durig U, Pohl D, Rohner F. Near-field optical-scanning microscopy. J Appl Phys. 1986;59:3318–3327. [Google Scholar]
  62. El Badawy AM, Silva RG, Morris B, Scheckel KG, Suidan MT, Tolaymat TM. Surface charge-dependent toxicity of silver nanoparticles. Environ Sci Technol. 2010;45:283–287. doi: 10.1021/es1034188. [DOI] [PubMed] [Google Scholar]
  63. Endres PJ, Paunesku T, Vogt S, Meade TJ, Woloschak GE. DNA–TiO2 nanoconjugates labeledwithmagnetic resonance contrast agents. J Am Chem Soc. 2007;129:15760–15761. doi: 10.1021/ja0772389. [DOI] [PubMed] [Google Scholar]
  64. Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomed Nanotechnol Biol Med. 2013;9:1–14. doi: 10.1016/j.nano.2012.05.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Euliss LE, DuPont JA, Gratton S, DeSimone J. Imparting size, shape, and composition control of materials for nanomedicine. Chem Soc Rev. 2006;35:1095–1104. doi: 10.1039/b600913c. [DOI] [PubMed] [Google Scholar]
  66. Farokhzad OC, Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev. 2006;58:1456–1459. doi: 10.1016/j.addr.2006.09.011. [DOI] [PubMed] [Google Scholar]
  67. Feng SS. Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev Med Devices. 2004;1:115–125. doi: 10.1586/17434440.1.1.115. [DOI] [PubMed] [Google Scholar]
  68. Ferrari M. Nanogeometry: beyond drug delivery. Nat Nanotechnol. 2008;3:131–132. doi: 10.1038/nnano.2008.46. [DOI] [PubMed] [Google Scholar]
  69. Filipe V, Hawe A, Jiskoot W. Critical evaluation of nanoparticle tracking analysis (NTA) by nanosight for the measurement of nanoparticles and protein aggregates. Pharm Res. 2010;27:796–810. doi: 10.1007/s11095-010-0073-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Fleming CJ, Liu YX, Deng Z, Liu GY. Deformation and hyperfine structures of dendrimers investigated by scanning tunneling microscopy. J Phys Chem A. 2009;113:4168–4174. doi: 10.1021/jp810535g. [DOI] [PubMed] [Google Scholar]
  71. Francius G, Domenech O, Mingeot-Leclercq MP, Dufrêne YF. Direct observation of Staphylococcus aureus cellwall digestion by lysostaphin. J Bacteriol. 2008;190:7904–7909. doi: 10.1128/JB.01116-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. French RA, Jacobson AR, Kim B, Isley SL, Penn RL, Baveye PC. Influence of ionic strength, pH, and cation valence on aggregation kinetics of titanium dioxide nanoparticles. Environ Sci Technol. 2009;43:1354–1359. doi: 10.1021/es802628n. [DOI] [PubMed] [Google Scholar]
  73. Fujie T, Park JY, Murata A, Estillore NC, Tria MCR, Takeoka S, et al. Hydrodynamic transformation of a freestanding polymer nanosheet induced by a thermoresponsive surface. ACS Appl Mater Interfaces. 2009;1:1404–1413. doi: 10.1021/am900111r. [DOI] [PubMed] [Google Scholar]
  74. Gadegaard N. Atomic force microscopy in biology: technology and techniques. Biotech Histochem. 2006;81:87–97. doi: 10.1080/10520290600783143. [DOI] [PubMed] [Google Scholar]
  75. Gautier C, Bürgi T. Vibrational circular dichroism of adsorbed molecules: BINAS on gold nanoparticles†. J Phys Chem C. 2010;114:15897–15902. [Google Scholar]
  76. Gebauer JS, Malissek M, Simon S, Knauer SK, Maskos M, Stauber RH, et al. Impact of the nanoparticle–protein corona on colloidal stability and protein structure. Langmuir. 2012;28:9673–9679. doi: 10.1021/la301104a. [DOI] [PubMed] [Google Scholar]
  77. Geng Y, Dalhaimer P, Cai SS, Tsai R, Tewari M, Minko T, et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol. 2007;2:249–255. doi: 10.1038/nnano.2007.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. George S, Lin S, Ji Z, Thomas CR, Li L, Mecklenburg M, et al. Surface defects on plate-shaped silver nanoparticles contribute to its hazard potential in a fish gill cell line and zebrafish embryos. ACS Nano. 2012;6:3745–3759. doi: 10.1021/nn204671v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Ghosh PS, Han G, Erdogan B, Rosado O, Krovi SA, Rotello VM. Nanoparticles featuring amino acid-functionalized side chains as DNA receptors. Chem Biol Drug Des. 2007;70:13–18. doi: 10.1111/j.1747-0285.2007.00534.x. [DOI] [PubMed] [Google Scholar]
  80. Gibson JD, Khanal BP, Zubarev ER. Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc. 2007;129:11653–11661. doi: 10.1021/ja075181k. [DOI] [PubMed] [Google Scholar]
  81. Gmoshinski IV, Khotimchenko SA, Popov VO, Dzantiev BB, Zherdev AV, Demin VF, et al. Nanomaterials and nanotechnologies: methods of analysis and control. Russ Chem Rev. 2013;82:48. [Google Scholar]
  82. Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed. 2007;18:241–268. doi: 10.1163/156856207779996931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A. 2008;105:11613–11618. doi: 10.1073/pnas.0801763105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Gref R, Minamitake Y, Peracchia M, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263:1600–1603. doi: 10.1126/science.8128245. [DOI] [PubMed] [Google Scholar]
  85. Grosso D, Ribot F, Boissiere C, Sanchez C. Molecular and supramolecular dynamics of hybrid organic–inorganic interfaces for the rational construction of advanced hybrid nanomaterials. Chem Soc Rev. 2011;40:829–848. doi: 10.1039/c0cs00039f. [DOI] [PubMed] [Google Scholar]
  86. Guay-Bégin A-A, Chevallier P, Faucher L, Turgeon S, Fortin M-A. Surface modification of gadoliniumoxide thin films and nanoparticles using poly(ethylene glycol)-phosphate. Langmuir. 2011;28:774–782. doi: 10.1021/la202780x. [DOI] [PubMed] [Google Scholar]
  87. Gugulothu D, Patravale V. Stability-indicating HPLC method for arteether and application to nanoparticles of arteether. J Chromatogr Sci. 2013 doi: 10.1093/chromsci/bmt125. http://dx.doi.org//10.1093/chromsci/bmt125 (in press). [DOI] [PubMed] [Google Scholar]
  88. Gun'ko V, Blitz J, Zarko V, Turov V, Pakhlov E, Oranska O, et al. Structural and adsorption characteristics and catalytic activity of titania and titania-containing nanomaterials. J Colloid Interface Sci. 2009;330:125–137. doi: 10.1016/j.jcis.2008.10.049. [DOI] [PubMed] [Google Scholar]
  89. Guo Z, Ganawi AA, Liu Q, He L. Nanomaterials in mass spectrometry ionization and prospects for biological application. Anal Bioanal Chem. 2006;384:584–592. doi: 10.1007/s00216-005-0125-3. [DOI] [PubMed] [Google Scholar]
  90. Hachani R, Lowdell M, Birchall M, Thanh NT. Tracking stem cells in tissue-engineered organs using magnetic nanoparticles. Nanoscale. 2013;5:11362–11372. doi: 10.1039/c3nr03861k. http://dx.doi.org/10.1039/c3nr03861k. [DOI] [PubMed] [Google Scholar]
  91. Hall JB, Dobrovolskaia MA, Patri AK, McNeil SE. Characterization of nanoparticles for therapeutics. Nanomedicine (London) 2007;2:789–803. doi: 10.2217/17435889.2.6.789. [DOI] [PubMed] [Google Scholar]
  92. Hansma PK, Elings VB, Marti O, Bracker CE. Scanning tunneling microscopy and atomic force microscopy: application to biology and technology. Science. 1988;242:209–216. doi: 10.1126/science.3051380. [DOI] [PubMed] [Google Scholar]
  93. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect. 2006;114:165–172. doi: 10.1289/ehp.8284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Hartschuh A. Tip-enhanced near-field optical microscopy. Angew Chem Int Ed. 2008;47:8178–8191. doi: 10.1002/anie.200801605. [DOI] [PubMed] [Google Scholar]
  95. Hathout RM, Mansour S, Mortada ND, Guinedi AS. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech. 2007;8:1. doi: 10.1208/pt0804080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Hayazawa N, Tarun A, Taguchi A, Furusawa K. Tip-enhanced Raman spectroscopy. In: Kumar CSR, editor. Raman spectroscopy for nanomaterials characterization. Berlin Heidelberg: Springer; 2012. pp. 445–476. [Google Scholar]
  97. Heinzelmann H, Pohl DW. Scanning near-field optical microscopy. Appl Phys A. 1994;59:89–101. [Google Scholar]
  98. Hind AR, Bhargava SK, McKinnon A. At the solid/liquid interface: FTIR/ATR—the tool of choice. Adv Colloid Interface Sci. 2001;93:91–114. doi: 10.1016/s0001-8686(00)00079-8. [DOI] [PubMed] [Google Scholar]
  99. Hinterdorfer P, Garcia-Parajo MF, Dufrene YF. Single-molecule imaging of cell surfaces using near-field nanoscopy. Acc Chem Res. 2012;45:327–336. doi: 10.1021/ar2001167. [DOI] [PubMed] [Google Scholar]
  100. Hondow N, Wang P, Brydson R, Holton M, Rees P, Summers H. TEM analysis of nanoparticle dispersions with application towards the quantification of in vitro cellular uptake. Journal of physics: conference series. IOP Publishing. 2012;012020 [Google Scholar]
  101. Horváth L, Magrez A, Burghard M, Kern K, Forró L, Schwaller B. Evaluation of the toxicity of graphene derivatives on cells of the lung luminal surface. Carbon. 2013;64:45–60. [Google Scholar]
  102. Huang J, Zong C, Shen H, Cao Y, Ren B, Zhang Z. Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy. Nanoscale. 2013a;5:10591–10598. doi: 10.1039/c3nr03264g. [DOI] [PubMed] [Google Scholar]
  103. Huang R, Carney RP, Stellacci F, Lau BLT. Protein–nanoparticle interactions: the effects of surface compositional and structural heterogeneity are scale dependent. Nanoscale. 2013b;5:6928–6935. doi: 10.1039/c3nr02117c. [DOI] [PubMed] [Google Scholar]
  104. Hull M, Bowman D. Nanotechnology environmental health and safety. Risks, regulation and management. 2009 [Access Online via Elsevier]. [Google Scholar]
  105. Hummer DR, Heaney PJ, Post JE. In situ observations of particle size evolution during the hydrothermal crystallization of TiO2: a time-resolved synchrotron SAXS and WAXS study. J Cryst Growth. 2012;344:51–58. [Google Scholar]
  106. Hurst SJ, Lytton-Jean AKR, Mirkin CA. Maximizing DNA loading on a range of gold nanoparticle sizes. Anal Chem. 2006;78:8313–8318. doi: 10.1021/ac0613582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Ianoul A, Johnston LJ. Near-field scanning optical microscopy to identify membrane microdomains. Methods Mol Biol. 2007;400:469–480. doi: 10.1007/978-1-59745-519-0_31. [DOI] [PubMed] [Google Scholar]
  108. Inagaki S, Ghirlando R, Grisshammer R. Biophysical characterization of membrane proteins in nanodiscs. Methods. 2013;59:287–300. doi: 10.1016/j.ymeth.2012.11.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Inokuchi Y, Hironaka K, Fujisawa T, Tozuka Y, Tsuruma K, Shimazawa M, et al. Physicochemical properties affecting retinal drug/coumarin-6 delivery fromnanocarrier systems via eyedrop administration. Invest Ophthalmol Vis Sci. 2010;51:3162–3170. doi: 10.1167/iovs.09-4697. [DOI] [PubMed] [Google Scholar]
  110. Ispas C, Andreescu D, Patel A, Goia DV, Andreescu S, Wallace KN. Toxicity and developmental defects of different sizes and shape nickel nanoparticles in zebrafish. Environ Sci Technol. 2009;43:6349–6356. doi: 10.1021/es9010543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Jiang X, Jiang J, Jin Y, Wang E, Dong S. Effect of colloidal gold size on the conformational changes of adsorbed cytochrome c: probing by circular dichroism, UV–visible, and infrared spectroscopy. Biomacromolecules. 2004;6:46–53. doi: 10.1021/bm049744l. [DOI] [PubMed] [Google Scholar]
  112. Jiang W, Kim BY, Rutka JT, Chan WC. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol. 2008;3:145–150. doi: 10.1038/nnano.2008.30. [DOI] [PubMed] [Google Scholar]
  113. Jiang X, Qu W, Pan D, Ren Y, Williford JM, Cui H, et al. Plasmid-templated shape control of condensed DNA-block copolymer nanoparticles. Adv Mater. 2013;25:227–232. doi: 10.1002/adma.201202932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Jin H, Wang N, Xu L, Hou S. Synthesis and conductivity of cerium oxide nanoparticles. Mater Lett. 2010;64:1254–1256. [Google Scholar]
  115. Jing B, Zhu Y. Disruption of supported lipid bilayers by semihydrophobic nanoparticles. J Am Chem Soc. 2011;133:10983–10989. doi: 10.1021/ja2040305. [DOI] [PubMed] [Google Scholar]
  116. Johal MS. Understanding nanomaterials. Boca Raton: CRC Press; 2011. [Google Scholar]
  117. Kane SR, Ashby PD, Pruitt LA. ATR–FTIR as a thickness measurement technique for hydrated polymer-on-polymer coatings. J Biomed Mater Res B Appl Biomater. 2009;91:613–620. doi: 10.1002/jbm.b.31436. [DOI] [PubMed] [Google Scholar]
  118. Kapralov AA, Feng WH, Amoscato AA, Yanamala N, Balasubramanian K, Winnica DE, et al. Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano. 2012;6:4147–4156. doi: 10.1021/nn300626q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Karlsson HL, Gustafsson J, Cronholm P, Möller L. Size-dependent toxicity of metal oxide particles—a comparison between nano- and micrometer size. Toxicol Lett. 2009;188:112–118. doi: 10.1016/j.toxlet.2009.03.014. [DOI] [PubMed] [Google Scholar]
  120. Kattumenu R, Lee C, Bliznyuk V, Singamaneni S. Micro-Raman spectroscopy of nanostructures. In: Kumar CSR, editor. Raman spectroscopy for nanomaterials characterization. Berlin Heidelberg: Springer; 2012. pp. 417–444. [Google Scholar]
  121. Kazarian SG, Chan KL. Applications of ATR–FTIR spectroscopic imaging to biomedical samples. Biochim Biophys Acta. 2006;1758:858–867. doi: 10.1016/j.bbamem.2006.02.011. [DOI] [PubMed] [Google Scholar]
  122. Khatun Z, Nurunnabi M, Cho KJ, Lee Y-k. Oral delivery of near-infrared quantum dot loaded micelles for noninvasive biomedical imaging. ACS Appl Mater Interfaces. 2012;4:3880–3887. doi: 10.1021/am301048m. [DOI] [PubMed] [Google Scholar]
  123. Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med. 2010;363:2434–2443. doi: 10.1056/NEJMra0912273. [DOI] [PubMed] [Google Scholar]
  124. Kim TH, Kim M, Park HS, Shin US, Gong MS, Kim HW. Size-dependent cellular toxicity of silver nanoparticles. J Biomed Mater Res A. 2012;100:1033–1043. doi: 10.1002/jbm.a.34053. [DOI] [PubMed] [Google Scholar]
  125. Kim TH, Lee S, Chen X. Nanotheranostics for personalized medicine. Expert Rev Mol Diagn. 2013;13:257–269. doi: 10.1586/erm.13.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Klesing J, Wiehe A, Gitter B, Gräfe S, Epple M. Positively charged calcium phosphate/polymer nanoparticles for photodynamic therapy. J Mater Sci Mater Med. 2010;21:887–992. doi: 10.1007/s10856-009-3934-7. [DOI] [PubMed] [Google Scholar]
  127. Kneipp J, Kneipp H, Wittig B, Kneipp K. Novel optical nanosensors for probing and imaging live cells. Nanomed Nanotechnol Biol Med. 2010;6:214–226. doi: 10.1016/j.nano.2009.07.009. [DOI] [PubMed] [Google Scholar]
  128. Knoppe S, Dharmaratne AC, Schreiner E, Dass A, Bürgi T. Ligand exchange reactions on Au38 and Au40 clusters: a combined circular dichroism and mass spectrometry study. J Am Chem Soc. 2010;132:16783–16789. doi: 10.1021/ja104641x. [DOI] [PubMed] [Google Scholar]
  129. Kobayashi N, Muranaka A, Mack J. Circular dichroism and magnetic circular dichroism spectroscopy for organic chemists. R Soc Chem. 2011 (ISBN: 1847558690). [Google Scholar]
  130. Kocum C, Cimen EK, Piskin E. Imaging of poly(NIPA-co-MAH)-HIgG conjugate with scanning tunneling microscopy. J Biomater Sci Polym Ed. 2004;15:1513–1520. doi: 10.1163/1568562042459706. [DOI] [PubMed] [Google Scholar]
  131. Kohli R, Mittal KL. Developments in surface contamination and cleaning-detection, characterization, and analysis of contaminants. William Andrew; 2011. [Google Scholar]
  132. Koningsberger DC, Prins R. X-ray absorption: principles, applications, techniques of EXAFS, SEXAFS, and XANES. New York: Wiley; 1988. [Google Scholar]
  133. Kostarelos K. The long and short of carbon nanotube toxicity. Nat Biotechnol. 2008;26:774–776. doi: 10.1038/nbt0708-774. [DOI] [PubMed] [Google Scholar]
  134. Krichevsky O, Bonnet G. Fluorescence correlation spectroscopy: the technique and its applications. Rep Prog Phys. 2002;65:251. [Google Scholar]
  135. Kumar CS. Raman spectroscopy for nanomaterials characterization. Springer Verlag; 2012. [Google Scholar]
  136. Kumar J, Thomas KG. Surface-enhanced Raman spectroscopy: investigations at the nanorod edges and dimer junctions. J Phys Chem Lett. 2011;2:610–615. [Google Scholar]
  137. Laera S, Ceccone G, Rossi F, Gilliland D, Hussain R, Siligardi G, et al. Measuring protein structure and stability of protein–nanoparticle systems with synchrotron radiation circular dichroism. Nano Lett. 2011;11:4480–4484. doi: 10.1021/nl202909s. [DOI] [PubMed] [Google Scholar]
  138. Lam T, Pouliot P, Avti PK, Lesage F, Kakkar AK. Superparamagnetic iron oxide based nanoprobes for imaging and theranostics. Adv Colloid Interface Sci. 2013;199–200:95–113. doi: 10.1016/j.cis.2013.06.007. [DOI] [PubMed] [Google Scholar]
  139. Lavigne J-P, Espinal P, Dunyach-Remy C, Messad N, Pantel A, Sotto A. Mass spectrometry: a revolution in clinical microbiology? Clin Chem Lab Med. 2013;51:257–270. doi: 10.1515/cclm-2012-0291. [DOI] [PubMed] [Google Scholar]
  140. Law SL, Huang KJ, Chiang CH. Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. J Control Release. 2000;63:135–140. doi: 10.1016/s0168-3659(99)00192-3. [DOI] [PubMed] [Google Scholar]
  141. Lee HM, Jin SM, Kim HM, Suh YD. Single-molecule surface-enhanced Raman spectroscopy: a perspective on the current status. Phys Chem Chem Phys. 2013a;15:5276–5287. doi: 10.1039/c3cp44463e. [DOI] [PubMed] [Google Scholar]
  142. Lee JP, Chen D, Li X, Yoo S, Bottomley LA, El-Sayed MA. Well-organized raspberry-like Ag@Cu bimetal nanoparticles for highly reliable and reproducible surface-enhanced Raman scattering. Nanoscale. 2013b;5:11620–11624. doi: 10.1039/c3nr03363e. http://dx.doi.org/10.1039/c3nr03363e. [DOI] [PubMed] [Google Scholar]
  143. Leung K, Chopra A, Shan L, Eckelman WC, Menkens AE. Essential parameters to consider for the characterization of optical imaging probes. Nanomedicine (Lond) 2012;7:1101–1107. doi: 10.2217/nnm.12.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Liang XJ, Chen C, Zhao Y, Jia L, Wang PC. Biopharmaceutics and therapeutic potential of engineered nanomaterials. Curr Drug Metab. 2008;9:697–709. doi: 10.2174/138920008786049230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Lim J, Yeap SP, Che HX, Low SC. Characterization of magnetic nanoparticle by dynamic light scattering. Nanoscale Res Lett. 2013;8:381. doi: 10.1186/1556-276X-8-381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Lin Z-H, Chang H-T. Preparation of gold–tellurium hybrid nanomaterials for surface-enhanced Raman spectroscopy. Langmuir. 2007;24:365–367. doi: 10.1021/la702543k. [DOI] [PubMed] [Google Scholar]
  147. Lin X-M, Cui Y, Xu Y-H, Ren B, Tian Z-Q. Surface-enhanced Raman spectroscopy: substrate-related issues. Anal Bioanal Chem. 2009;394:1729–1745. doi: 10.1007/s00216-009-2761-5. [DOI] [PubMed] [Google Scholar]
  148. Lin W-f, Li J-R, Liu G-y. Near-field scanning optical microscopy enables direct observation of moiré effects at the nanometer scale. ACS Nano. 2012;6:9141–9149. doi: 10.1021/nn303407j. [DOI] [PubMed] [Google Scholar]
  149. Lipfert J, Doniach S. Small-angle X-ray scattering from RNA, proteins, and protein complexes. Annu Rev Biophys Biomol Struct. 2007;36:307–327. doi: 10.1146/annurev.biophys.36.040306.132655. [DOI] [PubMed] [Google Scholar]
  150. Liu H, Webster TJ. Nanomedicine for implants: a review of studies and necessary experimental tools. Biomaterials. 2007;28:354–369. doi: 10.1016/j.biomaterials.2006.08.049. [DOI] [PubMed] [Google Scholar]
  151. Liu Y, Li W, Lao F, Liu Y, Wang L, Bai R, et al. Intracellular dynamics of cationic and anionic polystyrene nanoparticles without direct interaction with mitotic spindle and chromosomes. Biomaterials. 2011;32:8291–8303. doi: 10.1016/j.biomaterials.2011.07.037. [DOI] [PubMed] [Google Scholar]
  152. Liu L, Ma Y, Chen X, Xiong X, Shi S. Screening and identification of BSA bound ligands from Puerariae lobata flower by BSA functionalized Fe3O4 magnetic nanoparticles coupled with HPLC–MS/MS. J Chromatogr B. 2012;887–888:55–60. doi: 10.1016/j.jchromb.2012.01.008. [DOI] [PubMed] [Google Scholar]
  153. Liu W, Rose J, Plantevin S, Auffan M, Bottero J-Y, Vidaud C. Protein corona formation for nanomaterials and proteins of a similar size: hard or soft corona? Nanoscale. 2013;5:1658–1668. doi: 10.1039/c2nr33611a. [DOI] [PubMed] [Google Scholar]
  154. Lucas M, Riedo E. Invited review article: combining scanning probe microscopy with optical spectroscopy for applications in biology and materials science. Rev Sci Instrum. 2012;83:061101. doi: 10.1063/1.4720102. [DOI] [PubMed] [Google Scholar]
  155. Lundqvist M, Sethson I, Jonsson B-H. Transient interaction with nanoparticles “freezes” a protein in an ensemble of metastable near-native conformations†. Biochemistry. 2005;44:10093–10099. doi: 10.1021/bi0500067. [DOI] [PubMed] [Google Scholar]
  156. Luyts K, Napierska D, Nemery B, Hoet PHM. How physico-chemical characteristics of nanoparticles cause their toxicity: complex and unresolved interrelations. Environ Sci Process Impacts. 2013;15:23–38. doi: 10.1039/c2em30237c. [DOI] [PubMed] [Google Scholar]
  157. Magde D, Elson E, Webb WW. Thermodynamic fluctuations in a reacting system—measurement by fluorescence correlation spectroscopy. Phys Rev Lett. 1972;29:705–708. [Google Scholar]
  158. Mahajan KD, Fan Q, Dorcena J, Ruan G, Winter JO. Magnetic quantumdots in biotechnology— synthesis and applications. Biotechnol J. 2013 doi: 10.1002/biot.201300038. http://dx.doi.org/10.1002/biot.201300038. (in press). [DOI] [PubMed] [Google Scholar]
  159. Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S. Protein–nanoparticle interactions: opportunities and challenges. Chem Rev. 2011;111:5610–5637. doi: 10.1021/cr100440g. [DOI] [PubMed] [Google Scholar]
  160. Mannelli I, Marco MP. Recent advances in analytical and bioanalysis applications of noble metal nanorods. Anal Bioanal Chem. 2010;398:2451–2469. doi: 10.1007/s00216-010-3937-8. [DOI] [PubMed] [Google Scholar]
  161. Marti O, Ribi HO, Drake B, Albrecht TR, Quate CF, Hansma PK. Atomic force microscopy of an organic monolayer. Science. 1988;239:50–52. doi: 10.1126/science.3336773. [DOI] [PubMed] [Google Scholar]
  162. Mavrocordatos D, Pronk W, Boiler M. Analysis of environmental particles by atomic force microscopy, scanning and transmission electron microscopy. Water Sci Technol. 2004;50:9–18. [PubMed] [Google Scholar]
  163. McNaught AD, Wilkinson A. Compendium of chemical terminology. Oxford: Blackwell Science; 1997. [Google Scholar]
  164. McNeil SE. Nanotechnology for the biologist. J Leukoc Biol. 2005;78:585–594. doi: 10.1189/jlb.0205074. [DOI] [PubMed] [Google Scholar]
  165. Milani S, Baldelli Bombelli F, Pitek AS, Dawson KA, Rädler J. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano. 2012;6:2532–2541. doi: 10.1021/nn204951s. [DOI] [PubMed] [Google Scholar]
  166. Miles M, McMaster T, Carr H, Tatham A, Shewry P, Field J, et al. Scanning tunneling microscopy of biomolecules. J Vac Sci Technol A Vac Surf Films. 1990;8:698–702. [Google Scholar]
  167. Mirau PA, Naik RR, Gehring P. Structure of peptides on metal oxide surfaces probed by NMR. J Am Chem Soc. 2011;133:18243–18248. doi: 10.1021/ja205454t. [DOI] [PubMed] [Google Scholar]
  168. Mitragotri S. In drug delivery, shape does matter. Pharm Res. 2009;26:232–234. doi: 10.1007/s11095-008-9740-y. [DOI] [PubMed] [Google Scholar]
  169. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Baldelli Bombelli F, et al. Physical–chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc. 2011;133:2525–2534. doi: 10.1021/ja107583h. [DOI] [PubMed] [Google Scholar]
  170. Mullen DG, Fang M, Desai A, Baker JR, Orr BG, Banaszak Holl MM. A quantitative assessment of nanoparticle–ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates. ACS Nano. 2010;4:657–670. doi: 10.1021/nn900999c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci. 2008;101:239–253. doi: 10.1093/toxsci/kfm240. [DOI] [PubMed] [Google Scholar]
  172. Nakaya M, Kuwahara Y, Aono M, Nakayama T. Nanoscale control of reversible chemical reaction between fullerene C60 molecules using scanning tunneling microscope. J Nanosci Nanotechnol. 2011;11:2829–2835. doi: 10.1166/jnn.2011.3898. [DOI] [PubMed] [Google Scholar]
  173. Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009;8:543–557. doi: 10.1038/nmat2442. [DOI] [PubMed] [Google Scholar]
  174. Nienhaus GU, Maffre P, Nienhaus K. Studying the protein corona on nanoparticles by FCS. In: Sergey YT, editor. Methods in enzymology. Academic Press; 2013. pp. 115–137. [DOI] [PubMed] [Google Scholar]
  175. Oberdörster GEJ. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823–839. doi: 10.1289/ehp.7339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2005;2:8. doi: 10.1186/1743-8977-2-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Ong QK, Reguera J, Silva PJ, Moglianetti M, Harkness K, Longobardi M, et al. High-resolution scanning tunneling microscopy characterization of mixed monolayer protected gold nanoparticles. ACS Nano. 2013;7:8529–8539. doi: 10.1021/nn402414b. [DOI] [PubMed] [Google Scholar]
  178. Overgaag K, Liljeroth P, Grandidier B, Vanmaekelbergh D. Scanning tunneling spectroscopy of individual PbSe quantum dots and molecular aggregates stabilized in an inert nanocrystal matrix. ACS Nano. 2008;2:600–606. doi: 10.1021/nn7003876. [DOI] [PubMed] [Google Scholar]
  179. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol. 2007;73:1712–1720. doi: 10.1128/AEM.02218-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Pan BF, Cui DX, Gao F, He R. Growth of multi-amine terminated poly(amidoamine) dendrimerson the surface of carbon nanotubes. Nanotechnology. 2006;17:2483–2489. doi: 10.1088/0957-4484/17/10/008. [DOI] [PubMed] [Google Scholar]
  181. Pan G-H, Barras A, Boussekey L, Qu X, Addad A, Boukherroub R. Preparation and characterization of decyl-terminated silicon nanoparticles encapsulated in lipid nanocapsules. Langmuir. 2013;29:12688–12696. doi: 10.1021/la4029468. [DOI] [PubMed] [Google Scholar]
  182. Park S, Lee YK, Jung M, Kim KH, Chung N, Ahn EK, et al. Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Inhal Toxicol. 2007;19(Suppl. 1):59–65. doi: 10.1080/08958370701493282. [DOI] [PubMed] [Google Scholar]
  183. Park HK, Lim YT, Kim JK, Park HG, Chung BH. Nanoscopic observation of a gold nanoparticle-conjugated protein using near-field scanning optical microscopy. Ultramicroscopy. 2008;108:1115–1119. doi: 10.1016/j.ultramic.2008.04.024. [DOI] [PubMed] [Google Scholar]
  184. Park Y-H, Bae HC, Jang Y, Jeong SH, Lee HN, Ryu W-I, et al. Effect of the size and surface charge of silica nanoparticles on cutaneous toxicity. Mol Cell Toxicol. 2013;9:67–74. [Google Scholar]
  185. Parot P, Dufrêne YF, Hinterdorfer P, Le Grimellec C, Navajas D, Pellequer J-L, et al. Past, present and future of atomic force microscopy in life sciences and medicine. J Mol Recognit. 2007;20:418–431. doi: 10.1002/jmr.857. [DOI] [PubMed] [Google Scholar]
  186. Patri A, Dobrovolskaia M, Stern S, McNeil S, Amiji M. Nanotechnology for cancer therapy. CRC Press; 2006. Preclinical characterization of engineered nanoparticles intended for cancer therapeutics; pp. 105–138. [Google Scholar]
  187. Perevedentseva E, Cai PJ, Chiu YC, Cheng CL. Characterizing protein activities on the lysozyme and nanodiamond complex prepared for bio applications. Langmuir. 2010;27:1085–1091. doi: 10.1021/la103155c. [DOI] [PubMed] [Google Scholar]
  188. Petoukhov MV, Svergun DI. Applications of small-angle X-ray scattering to biomacromolecular solutions. Int J Biochem Cell Biol. 2013;45:429–437. doi: 10.1016/j.biocel.2012.10.017. [DOI] [PubMed] [Google Scholar]
  189. Petryayeva E, Algar WR, Medintz IL. Quantumdots in bioanalysis: a review of applications across various platforms for fluorescence spectroscopy and imaging. Appl Spectrosc. 2013;67:215–252. doi: 10.1366/12-06948. [DOI] [PubMed] [Google Scholar]
  190. Picas L, Milhiet PE, Hernandez-Borrell J. Atomic forcemicroscopy: a versatile tool to probe the physical and chemical properties of supported membranes at the nanoscale. Chem Phys Lipids. 2012;165:845–860. doi: 10.1016/j.chemphyslip.2012.10.005. [DOI] [PubMed] [Google Scholar]
  191. Pleus R. Nanotechnologies— guidance on physicochemical characterization of engineered nanoscale materials for toxicologic assessment. 2012 [Google Scholar]
  192. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008;3:423–428. doi: 10.1038/nnano.2008.111. [DOI] [PubMed] [Google Scholar]
  193. Ponce A, Mejia-Rosales S, Jose-Yacaman M. Scanning transmission electron microscopy methods for the analysis of nanoparticles. Methods Mol Biol. 2012;906:453–471. doi: 10.1007/978-1-61779-953-2_37. [DOI] [PubMed] [Google Scholar]
  194. Pons T, Medintz IL, Wang X, English DS, Mattoussi H. Solution-phase single quantum dot fluorescence resonance energy transfer. J Am Chem Soc. 2006a;128:15324–15331. doi: 10.1021/ja0657253. [DOI] [PubMed] [Google Scholar]
  195. Pons T, Uyeda HT, Medintz IL, Mattoussi H. Hydrodynamic dimensions, electrophoretic mobility, and stability of hydrophilic quantum dots. J Phys Chem B. 2006b;110:20308–20316. doi: 10.1021/jp065041h. [DOI] [PubMed] [Google Scholar]
  196. Popovic ZV, Dohcevic-Mitrovic Z, Scepanovic M, Grujic-Brojcin M, Askrabic S. Raman scattering on nanomaterials and nanostructures. Ann Phys. 2011;523:62–74. [Google Scholar]
  197. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci. 2006;90:296–303. doi: 10.1093/toxsci/kfj099. [DOI] [PubMed] [Google Scholar]
  198. Powers KW, Palazuelos M, Brown SC, Roberts SM. Characterization of nanomaterials for toxicological evaluation. In: Sahu S, Casciano D, editors. Nanotoxicology From In Vivo and In Vitro Models to Health Risks. 2009. pp. 1–27. [Google Scholar]
  199. Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3:785–796. doi: 10.1038/nrd1494. [DOI] [PubMed] [Google Scholar]
  200. Rahman M, Laurent S, Tawil N, Yahia LH, Mahmoudi M. Protein–nanoparticle interactions. Berlin Heidelberg: Springer; 2013. Analytical methods for corona evaluations; pp. 65–82. [Google Scholar]
  201. Ranjbar B, Gill P. Circular dichroism techniques: biomolecular and nanostructural analyses — a review. Chem Biol Drug Des. 2009;74:101–120. doi: 10.1111/j.1747-0285.2009.00847.x. [DOI] [PubMed] [Google Scholar]
  202. Rao CNR, Biswas K. Characterization of nanomaterials by physical methods. Annu Rev Anal Chem. 2009:435–462. doi: 10.1146/annurev-anchem-060908-155236. [Palo Alto: Annual Reviews]. [DOI] [PubMed] [Google Scholar]
  203. Ratner BD, Hoffman AS, Schoen FJ, Lemons JE. Biomaterials science: an introduction to materials in medicine. Academic Press; 2004. [Google Scholar]
  204. Ratnikova TA, Nedumpully Govindan P, Salonen E, Ke PC. In vitro polymerization of microtubules with a fullerene derivative. ACS Nano. 2011;5:6306–6314. doi: 10.1021/nn201331n. [DOI] [PubMed] [Google Scholar]
  205. Röcker C, Pötzl M, Zhang F, Parak WJ, Nienhaus GU. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol. 2009;4:577–580. doi: 10.1038/nnano.2009.195. [DOI] [PubMed] [Google Scholar]
  206. Rosenblum LT, Kosaka N, Mitsunaga M, Choyke PL, Kobayashi H. In vivo molecular imaging using nanomaterials: general in vivo characteristics of nano-sized reagents and applications for cancer diagnosis. Mol Membr Biol. 2010;27:274–285. doi: 10.3109/09687688.2010.481640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Rusu L, Gambhir A, McLaughlin S, Radler J. Fluorescence correlation spectroscopy studies of peptide and protein binding to phospholipid vesicles. Biophys J. 2004;87:1044–1053. doi: 10.1529/biophysj.104.039958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Sacchetti C, Motamedchaboki K, Magrini A, Palmieri G, Mattei M, Bernardini S, et al. Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance. ACS Nano. 2013;7:1974–1989. doi: 10.1021/nn400409h. [DOI] [PubMed] [Google Scholar]
  209. Sapsford KE, Tyner KM, Dair BJ, Deschamps JR, Medintz IL. Analyzing nanomaterial bioconjugates: a review of current and emerging purification and characterization techniques. Anal Chem. 2011;83:4453–4488. doi: 10.1021/ac200853a. [DOI] [PubMed] [Google Scholar]
  210. Schacher F, Betthausen E, Walther A, Schmalz H, Pergushov DV, Müller AHE. Interpolyelectrolyte complexes of dynamic multicompartment micelles. ACS Nano. 2009;3:2095–2102. doi: 10.1021/nn900110s. [DOI] [PubMed] [Google Scholar]
  211. Schaefer J, Schulze C, Marxer EE, Schaefer UF, Wohlleben W, Bakowsky U, et al. Atomic force microscopy and analytical ultracentrifugation for probing nanomaterial protein interactions. ACS Nano. 2012;6:4603–4614. doi: 10.1021/nn202657q. [DOI] [PubMed] [Google Scholar]
  212. Schwille P. Fluorescence correlation spectroscopy and its potential for intracellular applications. Cell Biochem Biophys. 2001;34:383–408. doi: 10.1385/CBB:34:3:383. [DOI] [PubMed] [Google Scholar]
  213. Shang L, Wang Y, Jiang J, Dong S. pH-Dependent protein conformational changes in albumin: gold nanoparticle bioconjugates: a spectroscopic study. Langmuir. 2007;23:2714–2721. doi: 10.1021/la062064e. [DOI] [PubMed] [Google Scholar]
  214. Shekunov BY, Chattopadhyay P, Tong HH, Chow AH. Particle size analysis in pharmaceutics: principles, methods and applications. Pharm Res. 2007;24:203–227. doi: 10.1007/s11095-006-9146-7. [DOI] [PubMed] [Google Scholar]
  215. Singh A, Sahoo SK. Magnetic nanoparticles: a novel platformfor cancer theranostics. Drug Discov Today. 2013 doi: 10.1016/j.drudis.2013.10.005. http://dx.doi.org/10.1016/j.drudis.2013.10.005. (in press). [DOI] [PubMed] [Google Scholar]
  216. Sinjab F, Lekprasert B, Woolley RAJ, Roberts CJ, Tendler SJB, Notingher I. Near-field Raman spectroscopy of biological nanomaterials by in situ laser-induced synthesis of tip-enhanced Raman spectroscopy tips. Opt Lett. 2012;37:2256–2258. doi: 10.1364/OL.37.002256. [DOI] [PubMed] [Google Scholar]
  217. Sohaebuddin S, Thevenot P, Baker D, Eaton J, Tang L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol. 2010;7:22. doi: 10.1186/1743-8977-7-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Song Y, Zhang Z, Elsayed-Ali HE, Wang H, Henry LL, Wang Q, et al. Identification of single nanoparticles. Nanoscale. 2011;3:31–44. doi: 10.1039/c0nr00412j. [DOI] [PubMed] [Google Scholar]
  219. Sosenkova L, Egorova E. The effect of particle size on the toxic action of silver nanoparticles. Journal of Physics: Conference Series. IOP Publishing. 2011:012027. [Google Scholar]
  220. Sperling RA, Liedl T, Duhr S, Kudera S, Zanella M, Lin CAJ, et al. Size determination of (bio) conjugated water-soluble colloidal nanoparticles: a comparison of different techniques. J Phys Chem C. 2007;111:11552–11559. [Google Scholar]
  221. Stolnik S, Illum L, Davis SS. Long circulating microparticulate drug carriers. Adv Drug Deliv Rev. 1995;16:195–214. [Google Scholar]
  222. Suzuki E. High-resolution scanning electron microscopy of immunogold-labelled cells by the use of thin plasma coating of osmium. J Microsc. 2002;208:153–157. doi: 10.1046/j.1365-2818.2002.01082.x. [DOI] [PubMed] [Google Scholar]
  223. Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N, et al. Induction of mesothelioma in p53+/&minus; mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci. 2008;33:105–116. doi: 10.2131/jts.33.105. [DOI] [PubMed] [Google Scholar]
  224. Tanaka K, Pescitelli G, Nakanishi K, Berova N. Fluorescence detected exciton coupled circular dichroism: development of new fluorescent reporter groups for structural studies. Monatsh Chem/Chem Mon. 2005;136:367–395. [Google Scholar]
  225. Tang Z, Xu B, Wu B, Germann MW, Wang G. Synthesis and structural determination of multidentate 2,3-dithiol-stabilized Au clusters. J Am Chem Soc. 2010;132:3367–3374. doi: 10.1021/ja9076149. [DOI] [PubMed] [Google Scholar]
  226. Tassa C, Duffner JL, Lewis TA, Weissleder R, Schreiber SL, Koehler AN, et al. Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles. Bioconjug Chem. 2009;21:14–19. doi: 10.1021/bc900438a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Thomas R, Park IK, Jeong YY. Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer. Int J Mol Sci. 2013;14:15910–15930. doi: 10.3390/ijms140815910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Tiede K, Boxall ABA, Tear SP, Lewis J, David H, Hassellöv M. Detection and characterization of engineered nanoparticles in food and the environment. Food Addit Contam Part A. 2008;25:795–821. doi: 10.1080/02652030802007553. [DOI] [PubMed] [Google Scholar]
  229. Tom RT, Samal AK, Sreeprasad TS, Pradeep T. Hemoprotein bioconjugates of gold and silver nanoparticles and gold nanorods: structure–function correlations. Langmuir. 2006;23:1320–1325. doi: 10.1021/la061150b. [DOI] [PubMed] [Google Scholar]
  230. Tomalia DA, Huang B, Swanson DR, Brothers HM, Klimash JW. Structure control within poly(amidoamine) dendrimers: size, shape and regio-chemical mimicry of globular proteins. Tetrahedron. 2003;59:3799–3813. [Google Scholar]
  231. Uskokovic V. Dynamic light scattering based microelectrophoresis: main prospects and limitations. J Disper Sci Technol. 2012;33:1762–1786. doi: 10.1080/01932691.2011.625523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Vaiyapuri R, Greenland BW, Rowan SJ, Colquhoun HM, Elliott JM, Hayes W. Thermoresponsive supramolecular polymer network comprising pyrene-functionalized gold nanoparticles and a chain-folding polydiimide. Macromolecules. 2012;45:5567–5574. [Google Scholar]
  233. Valentini M, Vaccaro A, Rehor A, Napoli A, Hubbell JA, Tirelli N. Diffusion NMR spectroscopy for the characterization of the size and interactions of colloidal matter: the case of vesicles and nanoparticles. J Am Chem Soc. 2004;126:2142–2147. doi: 10.1021/ja037247r. [DOI] [PubMed] [Google Scholar]
  234. Vancso GJ, Hillborg H, Schönherr H. Polymer analysis polymer theory. Berlin Heidelberg: Springer; 2005. Chemical composition of polymer surfaces imaged by atomic force microscopy and complementary approaches; pp. 55–129. [Google Scholar]
  235. Vertegel AA, Siegel RW, Dordick JS. Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. Langmuir. 2004;20:6800–6807. doi: 10.1021/la0497200. [DOI] [PubMed] [Google Scholar]
  236. Vinogradov SV, Bronich TK, Kabanov AV. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev. 2002;54:135–147. doi: 10.1016/s0169-409x(01)00245-9. [DOI] [PubMed] [Google Scholar]
  237. Vobornik D, Banks DS, Lu Z, Fradin C, Taylor R, Johnston LJ. Fluorescence correlation spectroscopy with sub-diffraction-limited resolution using near-field optical probes. Appl Phys Lett. 2008:93. [Google Scholar]
  238. Wagner AJ, Bleckmann CA, Murdock RC, Schrand AM, Schlager JJ, Hussain SM. Cellular interaction of different forms of aluminum nanoparticles in rat alveolar macrophages. J Phys Chem B. 2007;111:7353–7359. doi: 10.1021/jp068938n. [DOI] [PubMed] [Google Scholar]
  239. Wagner V, Hüsing B, Gaisser S, Bock A-K. Nanomedicine: drivers for development and possible impacts. JRC-IPTS Eur. 2008:23494. [Google Scholar]
  240. Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. What the cell “sees” in bionanoscience. J Am Chem Soc. 2010;132:5761–5768. doi: 10.1021/ja910675v. [DOI] [PubMed] [Google Scholar]
  241. Wang ZL. Characterization of nanophase materials. Wiley-VCH Verlag: GmbH; 2001. Transmission electron microscopy and spectroscopy of nanoparticles; pp. 37–80. [Google Scholar]
  242. Wang H, Chu PK. Chapter 4 — surface characterization of biomaterials. In: Amit B, Susmita B, editors. Characterization of biomaterials. Oxford: Academic Press; 2013. pp. 105–174. [Google Scholar]
  243. Wang Y, Irudayaraj J. Surface-enhanced Raman spectroscopy at single-molecule scale and its implications in biology. Philos Trans R Soc Lond B Biol Sci. 2013;368:20120026. doi: 10.1098/rstb.2012.0026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Wang L-Q, Exarhos GJ, Liu J. Characterization of nanophase materials. Wiley-VCH Verlag: GmbH; 2001. Nuclear magnetic resonance — characterization of self-assembled nanostructural materials; pp. 243–260. [Google Scholar]
  245. Wang T, Sridhar R, Korotcov A, Ting AH, Francis K, Mitchell J, et al. Synthesis of amphiphilic triblock copolymers as multidentate ligands for biocompatible coating of quantum dots. Colloids Surf A Physicochem Eng Asp. 2011;375:147–155. doi: 10.1016/j.colsurfa.2010.11.079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. Warheit DB, Webb TR, Sayes CM, Colvin VL, Reed KL. Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area. Toxicol Sci. 2006;91:227–236. doi: 10.1093/toxsci/kfj140. [DOI] [PubMed] [Google Scholar]
  247. Webster TJ. Nanomedicine: what's in a definition? Int J Nanomedicine. 2006;1:115. doi: 10.2147/nano.2006.1.2.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  248. Weiner BB, Tscharnuter WW, Fairhurst D. Zeta potential: a new approach. New York: Brookhaven Instruments Corporation; 1993. [Google Scholar]
  249. Wiesendanger R. Scanning probe microscopy and spectroscopy: methods and applications. Cambridge University Press; 1994. [Google Scholar]
  250. Williams DB, Carter CB. Transmission electron microscopy. Springer; 2009. The transmission electron microscope; pp. 3–22. [Google Scholar]
  251. Wilson AJ, Willets KA. Surface-enhanced Raman scattering imaging using noble metal nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013;5:180–189. doi: 10.1002/wnan.1208. [DOI] [PubMed] [Google Scholar]
  252. Wong BS, Yoong SL, Jagusiak A, Panczyk T, Ho HK, Ang WH. Carbon nanotubes for delivery of small molecule drugs. Adv Drug Deliv Rev. 2013 doi: 10.1016/j.addr.2013.08.005. http://dx.doi.org/10.1016/j.addr.2013.08.005. (in press). [DOI] [PubMed] [Google Scholar]
  253. Wu B, Chen Y, Muller JD. Fluorescence correlation spectroscopy of finite-sized particles. Biophys J. 2008;94:2800–2808. doi: 10.1529/biophysj.107.112789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  254. Xiao M, Nyagilo J, Arora V, Kulkarni P, Xu D, Sun X, et al. Gold nanotags for combined multi-colored Raman spectroscopy and x-ray computed tomography. Nanotechnology. 2010;21:035101. doi: 10.1088/0957-4484/21/3/035101. [DOI] [PubMed] [Google Scholar]
  255. Xu R. Progress in nanoparticles characterization: sizing and zeta potential measurement. Particuology. 2008;6:112–115. [Google Scholar]
  256. Yang L, Watts DJ. Particle surface characteristics may play an important role in phytotoxicity of alumina nanoparticles. Toxicol Lett. 2005;158:122–132. doi: 10.1016/j.toxlet.2005.03.003. [DOI] [PubMed] [Google Scholar]
  257. Yang PH, Sun XS, Chiu JF, Sun HZ, He QY. Transferrin-mediated gold nanoparticle cellular uptake. Bioconjug Chem. 2005;16:494–496. doi: 10.1021/bc049775d. [DOI] [PubMed] [Google Scholar]
  258. Yao H, Saeki M, Sasaki A. Boronic acid-protected gold clusters capable of asymmetric induction: spectral deconvolution analysis of their electronic absorption and magnetic circular dichroism. Langmuir. 2012;28:3995–4002. doi: 10.1021/la204731a. [DOI] [PubMed] [Google Scholar]
  259. Zak AK, Majid W, Darroudi M, Yousefi R. Synthesis and characterization of ZnO nanoparticles prepared in gelatin media. Mater Lett. 2011;65:70–73. [Google Scholar]
  260. Zanchet D, Hall BD, Ugarte D. Characterization of nanophase materials. Wiley-VCH Verlag: GmbH; 2001. X-ray characterization of nanoparticles; pp. 13–36. [Google Scholar]
  261. Zhao Y, Qiu X, Burda C. The effects of sintering on the photocatalytic activity of N-doped TiO2 nanoparticles. Chem Mater. 2008;20:2629–2636. [Google Scholar]
  262. Zhao T, Chen K, Gu H. Investigations on the interactions of proteins with polyampholyte-coated magnetite nanoparticles. J Phys Chem B. 2013;117:14129–14135. doi: 10.1021/jp407157n. http://dx.doi.org/10.1021/jp407157n. [DOI] [PubMed] [Google Scholar]
  263. Zhou C, Liu Z, Du X, Mitchell DR, Mai YW, Yan Y, et al. Hollow nitrogen-containing core/shell fibrous carbon nanomaterials as support to platinum nanocatalysts and their TEM tomography study. Nanoscale Res Lett. 2012;7:165. doi: 10.1186/1556-276X-7-165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  264. Zhu L, Attard P, Neto C. Reliable measurements of interfacial slip by colloid probe atomic force microscopy. II. Hydrodynamic force measurements. Langmuir. 2011;27:6712–6719. doi: 10.1021/la104597d. [DOI] [PubMed] [Google Scholar]

RESOURCES